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Abstract
Current studies suggest a relationship between microbes in the gut and the brain, including an impact on
brain disease development, severity, and progression. However, exploring this relationship is hindered by the
intricacies of mammalian models. Drosophila has the potential to be an excellent model organism for studies
of the gut-brain axis due to the relative simplicity of its microbiome, similarity to mammals, and efficient
methods to rear germ-free flies. To take advantage of this potential, I examined the gut-brain axis in
Drosophila models of autosomal recessive parkinsonism and observed a five-fold increase in the gut microbial
load of aged parkin animals. The microbial load of pink1 animals was unchanged, suggesting a
Pink1-independent role for parkin in maintaining microbial load numbers within normal range. Conditional
RNAi showed that parkin is required in gut enterocytes and not in neurons or muscle to maintain microbial
load homeostasis. Germ-free parkin flies exhibited improved resistance to paraquat, suggesting an impact of
the gut microbiome on toxin sensitivity in parkin flies. Sequencing of 16S rDNA revealed microbial species
with altered relative abundance in parkin null flies compared to controls. These data reveal a role for parkin
activity in maintaining microbial composition and abundance in the gut, suggesting a relationship between
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Current studies suggest a relationship between microbes in the gut and the brain, including 
an impact on brain disease development, severity, and progression. However, exploring 
this relationship is hindered by the intricacies of mammalian models. Drosophila has the 
potential to be an excellent model organism for studies of the gut-brain axis due to the 
relative simplicity of its microbiome, similarity to mammals, and efficient methods to rear 
germ-free flies. To take advantage of this potential, I examined the gut-brain axis in 
Drosophila models of autosomal recessive parkinsonism and observed a five-fold increase 
in the gut microbial load of aged parkin animals. The microbial load of pink1 animals was 
unchanged, suggesting a Pink1-independent role for parkin in maintaining microbial load 
numbers within normal range. Conditional RNAi showed that parkin is required in gut 
enterocytes and not in neurons or muscle to maintain microbial load homeostasis. Germ-
free parkin flies exhibited improved resistance to paraquat, suggesting an impact of the gut 
microbiome on toxin sensitivity in parkin flies. Sequencing of 16S rDNA revealed 
microbial species with altered relative abundance in parkin null flies compared to controls. 
These data reveal a role for parkin activity in maintaining microbial composition and 
abundance in the gut, suggesting a relationship between parkin function and the gut 
microbiome, and deepening our understanding of parkin and its mutant effects.  
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CHAPTER 1: INTRODUCTION 
The gut microbiome and its importance for health and disease of the brain 
Thousands of species and trillions of microbes inhabit the human gastrointestinal tract 
(Huttenhower et al. 2012). While their sheer number is striking (approximately as many 
as the number of human cells in the body (Sender, Fuchs, and Milo 2016)), it is only the 
beginning when it comes to their importance. The gut microflora has co-evolved with its 
host to secrete metabolites, including neurotransmitters, with the potential to impact 
human health and disease (Lin and Zhang 2016; Postler and Ghosh 2017; Martinez, 
Leone, and Chang 2017). Regulating this secretion are a set of microbial genomes, 
collectively termed the gut microbiome, which outnumber human genes by a factor of 
one thousand and account for a much larger human-to-human genetic diversity than the 
genes in the human genome alone (Friedrich 2008; Lloyd-Price, Abu-Ali, and 
Huttenhower 2016). Whereas human genomes are almost identical – and yet small 
differences can give rise to great diversity, including susceptibility to disease – it is 
estimated that only a third of genes are constant between the microbiomes of healthy 
humans (Lloyd-Price et al. 2016). Taken together, the size, diversity, and metabolic 
capacity of the gut microbiome suggest an immense impact on health and disease and a 
potential for the development of novel disease therapies.  
 
Even with these expectations in mind, recent discoveries on the role of the gut 
microbiome in many diseases have shown impact on a wide range of health conditions, 
2 
 
such as obesity (Hartstra et al. 2015), heart disease (Tang and Hazen 2017), and cancer 
(Schwabe and Jobin 2013). In many of these diseases, it has been shown both that the 
microbiomes of healthy and affected individuals differ, and that a microbial transplant 
from healthy individuals, either in humans or mammalian models, affects the severity of 
disease symptoms. Also emerging is research on the relationship between the gut 
microbiome and the brain, including mental health, neurodevelopmental, and 
neurodegenerative diseases (Sharon et al. 2016).  
 
A number of studies report a decrease in anxiety-like behaviors in germ-free compared to 
specific-pathogen-free mice (Clarke et al. 2012; Heijtz et al. 2011; Neufeld et al. 2011b; 
Neufeld et al. 2011a; Sudo et al. 2004). This reduction persists after subsequent 
association with microbiota derived from specific-pathogen-free mice, suggesting there is 
a critical period in development during which microbes in the gut exert their influence on 
anxiety-like behaviors (Neufeld et al. 2011a). The effect is also observed in the offspring 
of germ-free mice (Nishino et al. 2013). One study reports an increase in anxiety-like 
behavior in germ-free mice (Crumeyrolle-Arias et al. 2014), however genetic 
background, gender, experimental design, and the type of microbes colonizing the gut 
differ between studies, and how precisely these factors influence the relationship between 




On an organismal and systemic level, gut microbes appear to influence the early 
programming of the hypothalamic-pituitary-adrenal (HPA) axis, a system of three 
neuroendocrine glands that plays the major role in regulation of stress reactivity (Tsigos 
and Chrousos 2002), and the gut microbiome has also been shown to impact functioning 
of the HPA axis later in life (Clarke et al. 2012; García-Ródenas et al. 2006; Gareau et al. 
2007; Sudo et al. 2004; O'Mahony et al. 2009). Increased levels of corticosterone and 
adrenocorticotrophin, two HPA axis stress hormones, have been observed in germ-free 
mice compared to specific-pathogen-free mice in response to a restraint stress model 
(Sudo et al. 2004). Long-term changes in gut microbial composition have also been 
reported as a result of the maternal separation model of neonatal stress, suggesting 
composition of the gut microflora may contribute to the long-term effects of maternal 
separation on stress-reactivity and stress-related behaviors (García-Ródenas et al. 2006; 
O'Mahony et al. 2009). Notably, treatment with probiotics alleviates the long-term 
increase in corticosterone resulting from maternal separation (Gareau et al. 2007). Apart 
from the HPA axis, there might a direct link between gut microbes and the vagus nerve, 
as evidenced by induction of cFOS, a neuronal activation marker, in vagal sensory 
neurons in response to infection with pathogens (Goehler et al. 2008; Lyte et al. 2006). 
cFOS induction has also been reported in the paraventricular nucleus of the hypothalamus 
in response to feeding with a probiotic species, E coli, and a non-infectious strain of E. 




On a neurochemical level, increased turnover of serotonin has been observed in the 
striatum of germ-free mice, as well as increased expression of serotonin receptors in the 
hippocampus (Clarke et al. 2012; Heijtz et al. 2011; Neufeld et al. 2011a; Sudo et al. 
2004). Certain probiotic bacteria are also capable of metabolizing glutamate into GABA, 
an inhibitory signaling neurotransmitter linked to depression and anxiety (Barrett et al. 
2012; Higuchi, Hayashi, and Abe 1997). Upon infection with pathogenic bacteria, an 
increase in anxiety-like behaviors is associated with reduced hippocampal expression of 
BDNF, a neurochemical that plays a role in neuron survival, differentiation, and 
plasticity, and the effect is reversed by probiotic treatment (Bercik et al. 2010). Overall, 
more detailed mechanistic studies are needed to understand the pathways involved in the 
relationship between microbes in the gut, the nervous and neuroendocrine systems, and 
changes specific neurochemicals.   
 
The gut microbiome also plays a potential role in the development and severity of 
neurodevelopmental disorders. In a seminal study, Hsiao and colleagues examined the 
impact of gut microbes on the maternal immune activation (MIA) mouse model of 
autism, in which mimicking infection by injecting immunogenic compounds in the 
mother triggers maternal inflammation and an autism-like phenotype in the offspring, 
possibly through translocation of cytokines through the placenta and modulation of key 
neurodevelopmental pathways (Hsiao et al. 2013; Lombardo et al. 2017). The researchers 
found intestinal barrier defects and changes in the gut microbiome of MIA mice (Hsiao et 
al. 2013). Several other studies have reported differences in the gut microflora between 
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healthy controls and autism-spectrum individuals or autism model mice, although with 
lack of consistency in the specific bacterial taxa involved (Theije, Caroline G M de et al. 
2014; Parracho et al. 2005; Son et al. 2015; Finegold et al. 2010). However, an increase 
in Clostridium species is common between a few reports (Parracho, et al. 2005; Song, 
Liu, and Finegold 2004; Finegold et al. 2010). Treatment with the probiotic Bacteroides 
fragilis repaired the intestinal barrier defects, restored the healthy gut microbiome 
composition, and led to improvement in a subset of the autism-like symptoms in MIA 
mice, namely anxiety-like, repetitive, communicative, and sensory-motor behaviors 
(Hsiao et al. 2013). The authors hypothesized that intestinal permeability causes an 
exacerbation of these autism-like behaviors by allowing microbial metabolites from the 
gut to enter the bloodstream (Hsiao et al. 2013). Interleukin-6, a cytokine which is 
elevated in MIA mice, is known to control tight junction expression and intestinal barrier 
integrity (Hsiao et al. 2013; Turner 2009). Indeed, characterization of the metabolome of 
MIA and control mice revealed a change in 8% of metabolites, among which 4-EPS, 
which can be produced by gut microbes and has a proposed role in mouse communication 
(Hsiao et al. 2013; Lafaye et al. 2004). Treatment with 4-EPS was sufficient to induce 
anxiety-like behaviors in healthy mice, and elevated 4-EPS levels in sera from MIA mice 
were restored to normal by B. fragilis treatment (Hsiao et al. 2013). This study 
demonstrates how gut bacteria can have far-reaching effects on the brain when host 
defenses are compromised and hints at a promising role for targeted probiotic therapies in 
improving some of the symptoms of neurodevelopmental conditions.   
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Although initial studies are promising, further research into the link between the gut 
microbiome and the brain is hurdled by the complexity of the mammalian microbiome 
and the challenges presented by human subjects and mammalian models. 
 
Drosophila has the potential to be an excellent model for the study of the gut 
microbiome and disease 
Drosophila is known for the wide variety of molecular genetic tools it offers, which have 
facilitated many crucial discoveries of disease mechanisms and etiology, including those 
of neurodegenerative disease (Bier 2005; Marsh and Thompson 2006). Along with its 
genetic tractability, the characteristics of its gut microflora make it an excellent model 
organism for studies of the link between the gut microbiome and the brain. The fly gut 
microbiome is much simpler than that of mammals, with 2-20 species comprising more 
than 90 percent of all bacteria in the gut (Fink et al. 2013; Wong, Chaston, and Douglas 
2013), allowing for powerful reductionist studies. Of the common bacteria of the fly gut, 
the genera Lactobacillus and Enterococcus are also frequently found in the human gut 
(Arumugam et al. 2011; Eckburg et al. 2005; Qin et al. 2010). Germ-free flies can be 
reared efficiently, at a lower cost, and at much greater numbers compared to germ-free 
mammalian models, enabling experimental screens and studies that examine the impact 




Drosophila was the first multicellular invertebrate to be reared in germ-free conditions 
and the first to be monoassociated with a defined bacterial species, in studies dating back 
to the beginning of the 20th century (Sang 1959). In the late 1960s, Bakula discovered 
that gut microbes are passed from parent to offspring through contamination of the outer 
shell of the embryo (chorion) (Bakula 1969).  Microbial load (the number of live 
microbes) on the surface of the egg is initially low while diversity is high. As the larva 
feeds and grows, microbial load gradually increases until plateauing at the third instar 
stage (Broderick and Lemaitre 2012; Wong, Ng, and Douglas 2011). During pupation, 
both microbial load and diversity drastically plummet as determined by sequencing 
(Wong et al. 2011), and no live bacteria have been cultured from flies surgically removed 
from their pupal casing before eclosion (Bakula 1969), suggesting gut bacteria are 
eliminated in the process of pupation. The larval gut itself, however, is one of the few 
structures that is not completely broken down during pupation (Takashima et al. 2011). 
Instead, the adult midgut is created from larval midgut progenitors and the remainder of 
the larval midgut is enclosed within the adult gut, wrapped in an epithelial pouch (Mathur 
et al. 2010; Micchelli et al. 2011; Takashima et al. 2011). This pouch is easily visible as 
the yellow-green meconium in recently eclosed flies and is excreted shortly after 
eclosion, causing bacteria to not be present at detectable levels (either by culturing or 
sequencing) in the gut of very young (0-1d) flies (Broderick and Lemaitre 2012). Young 
(3d) animals have few living bacteria (approximately 100-1000), but bacterial numbers 
increase up to 1000-fold, along with an increase in diversity, as flies age (Broderick, 
Buchon, and Lemaitre 2014; Guo et al. 2014). As one can see, the gut microflora of 
Drosophila undergoes extensive changes throughout the life cycle of the animal, 
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suggesting that: 1) Microbial load and composition in the gut might have biological 
significance for the host, and 2) The number and diversity of gut-associated microbes 
might be regulated by the host on the molecular level. 
 
Regulation of the fly gut microbiome 
Drosophila tightly regulates its gut microbiome via a complex network that can be 
broken down into three major mechanisms/pathways, with crosstalk occurring between 
components of different pathways at many steps. The peritrophic matrix (PM), a net of 
chitin polymers and glycoproteins, lines the lumen of the gut and provides a physical 
barrier between the contents of the gut lumen and the gut epithelium (Hegedus et al. 
2009). The Duox pathway releases reactive oxygen species (ROS) in the lumen of the gut 
(Bae, Choi, and Lee 2010), whereas the Imd pathway secretes antimicrobial peptides 
(AMPs) to eliminate bacteria or restrict their growth (Myllymäki, Valanne, and Rämet 
2014). Gut microbes regulate each of these three mechanisms in a distinct fashion, 
resulting in a feedback loop between the host and its gut microbiota.  
 
Genes associated with chitin metabolism and PM maintenance are upregulated in the gut 
upon infection with pathogenic bacteria (Buchon et al. 2009). These genes appear to be 
regulated by Relish, a component of the Imd pathway, suggesting there is crosstalk 
between the different bacterial regulation mechanisms in the gut (Buchon et al. 2009). 
Mutation in the gene encoding Drosocrystallin, a component of the PM, results in 
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increased susceptibility to the pathogens Pseudomonas entomophila and Serratia 
marcescens (Kuraishi et al. 2011). Drosocrystallin, along with other PM glycoproteins, is 
crosslinked by the enzyme Transglutaminase (TG), and the crosslinked fibers are capable 
of adsorbing bacterial pore-forming toxins (Shibata et al. 2015). Unfortunately, not much 
is known about the interaction between the PM and commensal bacteria, although 
physical association with the PM would enable bacteria to form communities inside the 
gut despite the constant passage of food, and would explain the observation of a 
relatively stable bacterial count despite starvation (Michael Parisi, personal 
communication).  
 
The NADPH oxidase Duox is the first line of defense against opportunistic pathogens in 
the gut (Bae et al. 2010). Expression of the gene is controlled by the p38 mitogen-
activated protein kinase (MAPK) pathway and its downstream target, the transcription 
factor Atf2 (Buchon, Broderick, and Lemaitre 2013). The pathway is activated by 
bacterial-derived uracil binding to a yet-unknown G-protein coupled receptor on the 
surface of the gut epithelium (Lee et al. 2013). A secondary trigger is detection of 
bacterial-derived peptidoglycan by the Imd pathway, but the transcription factor Relish, 
which is responsible for Imd-mediated induction of AMPs, is not required for activation 
(Ha, Lee, Seo et al. 2009). Notably, uracil is released in the gut lumen in much higher 
levels by pathogenic compared to commensal bacteria, thus enabling the Duox pathway 
to distinguish friend from foe (Lee et al. 2013). The enzymatic activity of Duox provides 
another layer of regulation. Binding of uracil to a second unknown receptor leads to 
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activation phospholipase Cβ (PLCβ) and inositol-3-phosphate synthesis, which in turn 
causes release of calcium from ER stores and Duox activation (Ha, Lee, Park et al. 2009). 
PLCβ is also activated through the Hedgehog pathway, and transcription of Hedgehog is 
mediated by the same receptor which mediates transcription of Duox, providing crosstalk 
between transcriptional and enzymatic regulation of Duox (Lee et al. 2013; Lee et al. 
2015).  
 
The Imd pathway is induced by gram-negative bacteria. Binding of DAP-type 
peptidoglycan from the bacterial wall to either of the peptidoglycan recognition proteins 
(PGRPs) LC and LE causes dimerization of the receptor and activation of the 
downstream signaling cascade (Bosco-Drayon et al. 2012; Kaneko et al. 2004; Leulier et 
al. 2003; Neyen et al. 2012; Takehana et al. 2002).  Of these, PGRP-LC is found on the 
cell membrane, whereas PGRP-LE can be either intracellular or secreted in the gut lumen 
and can trigger Imd activity on its own or through enhancing peptidoglycan binding by 
PGRP-LC (Bosco-Drayon et al. 2012; Neyen et al. 2012). Receptor dimerization recruits 
the Imd and Fadd adaptors, along with the Dredd caspase, which in turn cleaves Imd, 
allowing Imd to be ubiquitinated by a complex containing Bendless, Effete, Uev1a, and 
DIAP2. Ubiquitinated Imd activates the Tak1 kinase, which phosphorylates the IKK 
protein complex, which in turn phosphorylates the NF-κB protein Relish. Dredd also 
cleaves the inhibitory subunit of Relish, and the cleaved and phosphorylated transcription 
factor enters the nucleus and activates transcription of AMPs (Buchon et al. 2013). 
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To avoid overactivation of the Imd pathway and constitutive inflammation, Relish 
promotes the transcription of several negative regulators of the pathway. Amidase PGRPs 
secreted in the gut bind to and cleave peptidoglycan to its monomers, which cannot be 
recognized by PGRP-LC and -LE (Mellroth, Karlsson, and Steiner 2003; Mellroth and 
Steiner 2006; Zaidman-Rémy et al. 2011; Paredes et al. 2011). On the cell membrane, 
PGRP-LF binds to peptidoglycan, but since it lacks a signaling domain, it cannot trigger 
the pathway and instead sequesters the pathway-activating ligand (Basbous et al. 2011; 
Maillet et al. 2008). Another negative regulator, Pirk (poor Imd response upon knock-in), 
mediates internalization of PGRP-LC and sequestering from the membrane by the cell 
(Aggarwal et al. 2008; Kleino et al. 2008; Lhocine et al. 2008). In the absence of immune 
challenge, Pirk expression is activated by the Ras/MAPK pathway (Ragab et al. 2011). 
Notably, this pathway is activated by ROS, providing another point of interaction 
between Duox and the Imd pathway (Choi et al. 2008). In the posterior midgut, the 
homeobox transcription factor Caudal represses transcription of AMPs, allowing 
commensal microbiota to thrive in this region (Ryu et al. 2008).  
 
Impact of the fly gut microbiome 
The complex and fine-tuned regulation of microbial homeostasis in the fly is warranted 
by the immense impact gut microbes have on many aspects of the host’s health and 
behavior. The gut microflora can influence lifespan (Brummel et al. 2004; Ren et al. 
2007), larval development (Shin et al. 2011; Storelli et al. 2011), metabolism (Newell and 
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Douglas 2014; Dobson et al. 2015; Chaston et al. 2016), and even mating preferences 
(Sharon et al. 2011) of the fly. 
 
Studies with germ-free flies report a complex impact on lifespan that has yet to be fully 
clarified. Brummel and colleagues observed shortened lifespan of germ-free flies 
compared to conventionally raised controls (Brummel et al. 2004). Exposure to microbes 
at different ages revealed that the gut microbiota extend lifespan if present in the first 
seven days of life and slightly shorten lifespan if present in old animals.  However, Ren 
and colleagues observed no impact of the gut microbiota on lifespan (Ren et al. 2007), 
suggesting that additional factors, such as diet and genotype, may play a role.  
 
Larval development is delayed in germ-free flies (Shin et al. 2011; Storelli et al. 2011). 
This effect can be rescued by supplementing the fly food with dead yeast, suggesting that 
gut microbes are necessary for processing nutrients in the food or for enhancing nutrient 
assimilation (Shin et al. 2011; Storelli et al. 2011). Association with Lactobacillus 
plantarum, a species commonly found in the fly gut, is sufficient to rescue the 
developmental delay under conditions of nutrient scarcity (Storelli et al. 2011). L. 
plantarum activates production of insulin-like peptides through the TOR kinase pathway, 
stimulating increased growth rate and enhanced protein absorption. It is not known how 
TOR pathway activity is stimulated by the microbe, but the effect appears to be 
independent of lactic acid production, a hallmark of Lactobacilli, since association with a 
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strain which produces less lactic acid is still sufficient to rescue larval development 
(Storelli et al. 2011). Another species, Acetobacter pomorum, also promotes larval 
development through insulin-like peptide signaling (Shin et al. 2011). The activity of 
pyrroloquinoline quinone–dependent alcohol dehydrogenase (PQQ-ADH) in Acetobacter 
is necessary for the rescue (Shin et al. 2011).  
 
The impact of the gut microbiota on fly metabolism is evidenced by the elevated glucose 
and triglyceride content in germ-free flies (Newell and Douglas 2014). A study aimed to 
identify the specific bacteria responsible found that monoassociation with any of five 
Acetobacter and Lactobacillus species was sufficient to rescue glucose levels (Newell 
and Douglas 2014). Only flies associated with both an Acetobacter and a Lactobacillus 
species, however, had triglyceride levels restored to a normal range, suggesting that 
certain aspects of Drosophila metabolism depend on the interaction between microbial 
species in the gut rather than on the presence of any individual species (Newell and 
Douglas 2014).  
 
Host genotype is another strong mediator of the impact of gut microbiota on Drosophila 
metabolism. A study evaluated germ-free flies from 108 different Drosophila lines on 
several metabolic metrics and compared them to matched conventionally raised controls 
(Dobson et al. 2015). The impact of microbiome removal varied significantly with host 
genotype. The authors followed up this result with genome-wide association experiments, 
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which uncovered single-nucleotide polymorphisms (SNPs) in a multitude of different 
pathways, including TOR signaling, which has been reported to mediate the impact of the 
gut microbiome on larval development (Storelli et al. 2011). Two notable hits were the 
gene dunce and the nicotinic Acetylcholine Receptor α2 gene nAChRα2, involved in 
axonal outgrowth and synaptic transmission respectively, supporting the existence of a 
gut-brain axis in Drosophila (Takemura et al. 2011; Zhong and Wu 2004).  
 
A follow-up study suggested that one of the major ways in which host genes mediate the 
relationship between gut microbes and metabolism is by regulating the identity of the gut 
microbes themselves (Chaston et al. 2016). The authors compared microbial composition 
and metabolic profile of 79 Drosophila lines and found an association between 
abundance of bacteria from the Acetobacteriaceae and Xantomonadaceae families and 
host metabolic traits. Genome-wide association experiments identified a list of SNPs in 
genes associated with variations in the abundance of the species Acetobacter tropicalis in 
the gut. The gene dunce was once again a strong hit, along with para, a gene encoding a 
voltage-gated sodium channel with an identified role in courtship and mechanosensory 
behaviors (Engel and Wu 1994; Peixoto and Hall 1998). Loss-of-function mutations for 





The gut microbiota influence Drosophila mating preference, possibly through altering 
sex pheromones (Sharon et al. 2011; Peixoto and Hall 1998, 827-38). Sharon et al. 
observed that isogenic flies reared on either starch or molasses medium would 
preferentially mate with flies reared on the same medium, and the mating preference was 
abolished by antibiotic treatment. When antibiotic-treated flies were inoculated with 
Lactobacillus species isolated from either the molasses or starch medium, flies 
preferentially mated with partners harboring the same bacteria. Analysis of cuticular 
hydrocarbons revealed differences in levels of several sex pheromones between starch-
bred and molasses-bred flies. The study supports the hologenome theory of evolution, 
which postulates that the host individual and the associated microbiota act together as a 
unit of natural selection (Zilber‐Rosenberg and Rosenberg 2008).  
 
Collectively, these studies demonstrate the power of Drosophila as a model organism for 
gut microbiome studies and its potential to reveal not only the impact of the microbiome, 
but the mechanisms, genes, and microbial species involved. Such discoveries can be 
instrumental in unraveling the impact of the gut microflora on diseases of the brain, 
including Parkinson's Disease. 
 
Parkinson's Disease and its associated pathways  
Among brain-related diseases, Parkinson’s disease (PD) is the most prevalent 
neurodegenerative movement disorder, occurring in approximately 1% of the population 
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over the age of 60 (Olanow and Brundin 2013). The disease is characterized initially by 
motor symptoms -- tremor, rigidity, stiff gate, and difficulty in maintaining balance – and 
in later stages by progressive dementia (Poewe et al. 2017). On the tissue level, neuronal 
death is most apparent in the substantia nigra pars compacta, and post mortem 
examinations reveal loss of 50-70% of neurons compared to unaffected individuals 
(Davie 2008). Cells in affected regions contain protein aggregates called Lewy bodies, 
which are comprised of a granular core containing various ubiquitinated and otherwise 
modified proteins, and a halo rich in α-synuclein (Olanow and Brundin 2013).  
 
Parkinson’s Disease occurs mostly sporadically, but 5%-10% of cases are due to heritable 
genetic mutations, the most often detected mutations being in the genes encoding α-
synuclein (SNCA), Parkin (PARK2), Pink1 (PARK6), and DJ-1 (PARK7) (Bonifati et al. 
2003; Kitada et al. 1998; Polymeropoulos et al. 1997; Valente et al. 2004). Animal 
models of familial PD have been helpful in piecing together the pathways associated with 
the disease.  
 
Point mutations of α-synuclein cause autosomal dominant familial Parkinson’s Disease 
(Polymeropoulos et al. 1997). Duplications and triplications of the gene also lead to 
familial PD, and some common variants have been shown to be associated with sporadic 
PD in genome-wide association studies (Chartier-Harlin et al. 2001; Ibáñez et al. 2004; 
Singleton et al. 2003). α-synuclein levels are high in the nervous system, particularly in 
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presynaptic terminals, and expression is altered in conditions affecting synaptic plasticity, 
suggesting that the protein functions as a modulator of synaptic transmission (George et 
al. 1995; Kholodilov et al. 1999; Vila et al. 2000). However, it appears that protein 
folding rather than function is its most pathogenic characteristic. α-synuclein normally 
folds into an α-helix-rich structure, but it can also assume a β-sheet-rich conformation 
under conditions that are not yet well known (Olanow and Brundin 2013). The change in 
conformation might be stochastic, or it might be influenced by age, inflammation, and 
oxidative stress (Olanow and Brundin 2013). The β-sheet-rich form of the protein is 
prone to aggregation into oligomers, which can be toxic to the cell, and which eventually 
aggregate further into insoluble fibrils (Olanow and Brundin 2013; Stefanis 2012). The 
aggregates interfere with the functioning of the ubiquitin proteasomal system, thus 
disrupting the clearance of aberrant proteins in a vicious cycle (Cuervo et al. 2004; 
Martinez-Vicente et al. 2008; Snyder et al. 2003; Tanaka et al. 2001).     
 
Mutations in the serine/threonine kinase Pink1 and the E3 ubiquitin ligase Parkin lead to 
autosomal recessive juvenile parkinsonism (AR-JP), a type of PD that occurs before age 
40, responds well to levodopa, and is not associated with the presence of Lewy bodies 
(Kitada et al. 1998; Saito et al. 2000; Valente et al. 2004). Much of what we know about 
the roles of Parkin and Pink1 has been discovered thanks to fly mutants. The individual 
characteristics of parkin and pink1 flies are similar and point towards a mitochondrial 
pathway. These models exhibit parkinsonism-like motor impairments, as demonstrated 
by their inability to climb the walls of their vials in climbing assays, as well as muscle 
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degeneration leading to abnormal wing posture and a collapsed dorsal thorax (Clark et al. 
2006; Greene et al. 2003; Park et al. 2006). Male loss of function mutants show abnormal 
sperm cell development and are sterile (Clark et al. 2006; Greene et al. 2003). Both 
muscle and sperm are cell types with high energy requirements, and upon inspection, 
these cells exhibit swollen mitochondria (Clark et al. 2006; Greene et al. 2003). The 
animals have shortened lifespan and are sensitive to oxidative and mitochondrial-targeted 
toxins such as paraquat and rotenone (Clark et al. 2006; Pesah et al. 2004). 
Overexpression of parkin rescues the muscle defects in pink1 mutants, whereas pink1 
overexpression does not rescue parkin loss-of-function muscle defects (Poole et al. 2010; 
Clark et al. 2006). Double knockout of pink1 and parkin does not result in more severe 
muscle degeneration than that in individual loss-of-function mutants (Poole et al. 2010; 
Clark et al. 2006).  
 
These findings point towards a role of Parkin and Pink1 in a mitochondrial pathway, and 
indeed, further molecular studies revealed Pink1 and Parkin are involved in clearance in 
damaged mitochondria (Deas, Wood, and Plun-Favreau 2011). In the absence of 
mitochondrial damage, Pink1 is constantly synthesized and then rapidly degraded, but 
damage resulting in mitochondrial depolarization causes Pink1 to accumulate on the 
outer mitochondrial membrane (OMM) (Meissner et al. 2011; Narendra et al. 2010; Jin et 
al. 2010). Stabilized Pink1 phosphorylates the ubiquitin-like domain of Parkin, as well as 
the ubiquitin substrate itself, leading to recruitment of Parkin to the OMM and activation 
(Jin et al. 2010; Kane et al. 2014; Kazlauskaite et al. 2014; Kondapalli et al. 2012; 
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Koyano et al. 2014; Shiba-Fukushima et al. 2014). Parkin, an E3 ligase, ubiquitinates 
multiple mitochondrial and cytosolic targets, eventually resulting in engulfment, 
degradation, and recycling of the damaged mitochondrion (Sarraf et al. 2013). A 
disruption in this pathway through genetic mutations, environmental toxins, or other 
factors leads to accumulation of damaged mitochondria and oxidative stress, which in 
turn can cause aberrant protein folding and cellular toxicity. Additional roles for Pink1 
and Parkin have been discovered in regulating mitochondrial fission and fusion, as well 
as mediating intestinal stem cell proliferation (Koehler et al. 2017; Poole et al. 2010). 
Parkin has also been shown to ubiquitinate and activate the NF-kB pathway component 
NEMO in a manner independent of Pink1 activity (Müller-Rischart et al. 2013). In 
worms, flies, and mammals, Parkin ubiquitinates intracellular pathogens, targeting them 
for clearance, and whether Pink1 activity is required for this process is unknown 
(Manzanillo et al. 2013).  
 
Deletions and points mutations in DJ-1 cause early-onset familial Parkinson’s Disease, 
most often with a recessive inheritance pattern (Ariga et al. 2013; Bonifati et al. 2003). 
The protein is present in almost all cells and tissues, including neurons and glia in the 
CNS (Yanagida et al. 2006; Bader et al. 2005; Bonifati et al. 2003; Nagakubo et al. 1997; 
Rizzu et al. 2004). Expression is increased under conditions of oxidative stress, and 
increased expression levels has been detected post mortem in sporadic PD cases 
(Bandopadhyay et al., 2004; Rizzu et al., 2004). DJ-1 senses oxidative stress through 
oxidation of its cysteine residues, C46, C56, and C106, of which C106 is most 
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susceptible to oxidation and point mutations targeting this residue result in complete loss 
of function (Canet-Avilés et al. 2004; Kinumi et al. 2004; Shendelman et al. 2004; Taira 
et al. 2004). Elevated levels of oxidized DJ-1 have been detected in the brains of patients 
with Parkinson’s Disease (Bandopadhyay et al. 2004). The cysteines act as quenchers of 
oxidative stress and switch the protein to its active form, in which it protects the cell from 
harmful excess of ROS by functioning as a transcription factor, protease, chaperone, and 
a regulator of mitochondrial homeostasis (Canet-Avilés et al. 2004; Shendelman et al. 
2004; Taira et al. 2004; Hayashi et al. 2009).  
 
Possible link between the gut microbiome and Parkinson’s Disease 
There is substantial clinical and experimental evidence to suggest that the gut 
microbiome plays a role in the pathology of PD. Gastrointestinal dysfunction is the most 
common non-motor symptom of PD (Pfeiffer 2003), and patients are at higher risk to 
suffer from small intestinal bacterial overgrowth compared to unaffected individuals 
(Gabrielli et al. 2011; Fasano et al. 2013; Parlesak et al. 2003; Tan et al. 2014). Several 
sequencing studies report changes in the microbial composition of stool samples from 
patients with the disease compared to unaffected individuals (Hasegawa et al. 2015; 
Keshavarzian et al. 2015; Scheperjans et al. 2015; Unger et al. 2016). In an α-synuclein 
overexpression mouse model, removal of the gut microbiota with antibiotics relieved 
both gastrointestinal and motor characteristics of the model (Sampson et al. 2016). 
Aggregation of α-synuclein and activation of microglia were also reduced. Since short 
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chain fatty acids (SCFAs) secreted from the gut microbiota induce microglial activation 
during development (Erny et al. 2015), the authors hypothesized that SCFAs might 
promote an increase in motor and gastrointestinal phenotypes when gut microbes are 
present. Indeed, germ-free animals treated with SCFAs exhibited a worsening of PD-
related traits (Sampson et al. 2016) 
 
The purpose of this doctoral work is to take advantage of Drosophila’s genetic 
tractability and potential for microbiome studies in characterizing a possible relationship 
between microbes in the gut and the Drosophila parkinsonism model parkin. I describe a 
study following up on a targeted screen examining changes in the gut microbial load of 
the fly parkinsonism models parkin, pink1, and DJ-1, in which 20d old parkin males 
were found to have an elevated number of live microbes in the gut compared to wild-type 
controls. This work enhances our understanding of the parkin mutation effects, as well as 
our understanding of the relationship between microbes in the gut and parkinsonism as 









Figure 1. Summary of Parkin’s known targets, biological functions, and associated 
phenotypes.  
Green rectangles indicate pathway targets. Cyan rectangles indicate biological functions. 
Violet diamonds indicate associated phenotypes. Upon activation by Pink1, Parkin 
ubiquitinates various targets in damaged mitochondria to mark them for mitophagy, 
among which the mitofusins Mfn1 and Mfn2, thus preventing fusion of the damaged 
mitochondria with healthy ones (Deas, Wood, and Plun-Favreau 2011). Pink1 and Parkin 
also mediate intestinal stem cell proliferation through an unknown pathway (Koehler et 
al. 2017). Parkin ubiquitinates the NF-κB protein NEMO independently of Pink1, 
resulting in activation of the NF-κB pathway and enhanced transcription of the 
mitochondrial fusion and apoptosis regulation protein OPA1 (Müller-Rischart et al. 
2013). Parkin ubiquitinates intracellular bacteria, targeting them for degradation. Whether 
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CHAPTER 2: ROLE AND IMPACT OF THE GUT MICROBIOTA IN A 
DROSOPHILA MODEL FOR PARKINSONISM 
 
Abstract 
Drosophila is poised to be a powerful model organism for studies of the gut-brain axis due 
to the relative simplicity of its microbiome, similarity to mammals, and efficient methods 
to rear germ-free flies. I examined the gut-brain axis in Drosophila models of autosomal 
recessive parkinsonism and discovered a relationship between the gut microbiome and 
parkin loss of function. The number of live bacteria was increased approximately five-fold 
in the gut of aged parkin null animals. Conditional RNAi showed that parkin is required in 
gut enterocytes and not in neurons or muscle to maintain microbial load homeostasis. To 
examine the significance of gut microbiota, we reared germ-free parkin flies and 
discovered that removal of microbes in the gut improves the animals’ resistance to 
paraquat. Sequencing of 16S rDNA revealed microbial species with altered relative 
abundance in parkin null flies compared to controls. These data reveal a role for parkin 
activity in maintaining microbial composition and abundance in the gut, suggesting a 
relationship between parkin function and the gut microbiome, and deepening our 
understanding of parkin and its mutant effects.  
Introduction 
Current studies have uncovered a fascinating link between the gut microbiome and the 
brain (Mayer, Savidge, and Shulman 2014; Sharon et al. 2016). For instance, alterations 
in the gut microbiota have been shown to affect host neurotransmitter levels, and anxiety- 
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and depression-like symptoms (Bravo et al. 2011; Wong et al. 2016). In addition, studies 
suggest that changes in the gut microbiome are correlated with the development and 
severity of diseases such as autism and Parkinson’s disease (Hsiao et al. 
2013;Scheperjans et al. 2015; Sampson et al. 2016). As promising as these initial studies 
are, in-depth research into the link between microbes in the gut and disease of the brain is 
challenging given the complexity of the mammalian microbiome and the intricacies 
presented by mammalian models.   
 
The genetics powerhouse of Drosophila has the potential to facilitate breakthrough 
studies of the gut microbiome and its relation to disease. The microflora of the fly gut is 
simpler than that of mammals, with up to 20 species comprising more than 90 percent of 
all bacteria in the gut (Fink et al. 2013; Wong, Chaston, and Douglas 2013), allowing for 
powerful reductionist studies. Of the well-known residents of the fly gut, the genera 
Lactobacillus and Enterococcus are also commonly present in the human gut microflora 
(Eckburg et al. 2005; Qin et al. 2010, Arumugam et al. 2011). One can rear germ-free 
flies efficiently and at lower cost compared to mammals, enabling experimental screens 
and studies that examine the impact of the gut microbiota on various disease models.  
 
Drosophila microbiome is passed from parent to larvae through contamination of the 
embryonic shell (chorion), which the larvae consume after hatching. The larval 
microbiome develops as the growing larvae eat, until reaching a plateau at the third instar 
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stage, and it is then eliminated during the pupal stage. Newly eclosed adult flies have no 
detectable microflora (by culturing or sequencing methods), and the gut microbiome 
grows in number and evolves in composition as the animals age (Broderick and Lemaitre 
2012).  
 
We sought to harness the potential of the fly with a screen to investigate the gut/brain 
axis in fly models of human disease. Drosophila disease models have contributed to 
crucial discoveries of disease mechanisms and etiology due to the wide array of available 
molecular genetic tools and the many conserved genes and pathways (Bier 2005; Marsh 
and Thompson 2006). We started by measuring gut microbial abundance in loss-of-
function mutants for genes associated with recessive parkinsonism: parkin (park), PTEN-
induced putative kinase 1 (pink1), and DJ-1. It is thought that the main contribution of 
Pink1 and Parkin to development of PD is through a pathway in which both proteins 
work towards maintaining mitochondrial fidelity (Park et al. 2006; Greene et al. 2003). In 
healthy mitochondria, Pink1 is rapidly degraded, but mitochondrial damage and 
depolarization causes Pink1 to accumulate on the outer mitochondrial membrane (OMM) 
(Jin et al. 2010; Narendra et al. 2010; Meissner et al. 2011). Pink1 phosphorylates Parkin 
and ubiquitin, and this kinase activity results in recruitment of Parkin to the mitochondria 
and activation (Kondapalli et al. 2012; Shiba-Fukushima et al. 2012; Shiba-Fukushima et 
al. 2014; Kane et al. 2014; Kazlauskaite et al. 2014; Koyano et al. 2014). Activated 
Parkin ubiquitinates multiple mitochondrial and cytosolic targets, eventually leading to 
engulfment of the damaged mitochondrion (Sarraf et al. 2013). Parkin has also been 
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shown to regulate mitochondrial fission and fusion, protect against intracellular bacterial 
pathogens, and together with pink1 play a role in intestinal stem cell proliferation (Deng 
et al. 2008; Park et al. 2006; Poole et al. 2008; Manzanillo et al. 2013). DJ-1 senses 
oxidative stress through oxidation of its cysteine residues and protects the cell from the 
harmful effects of reactive oxygen species by acting as a transcription factor, protease, 
chaperone, and a regulator of mitochondrial homeostasis (Taira et al. 2004; Canet-Avilés 
et al. 2004; Martinat et al. 2004; Hayashi et al. 2009). 
 
We found a link between the gut microbiome and parkin flies. Here we describe a series 
of experiments to examine and characterize the relationship between parkin gene 
function and the gut microbiota. We observed a significantly increased microbial load 
and an altered relative species abundance in the gut microbiomes of parkin mutants 
compared to wild-type controls. Conditional in vivo RNAi revealed a requirement for 
Parkin in gut enterocytes to maintain microbial load within the wild-type range. 
Furthermore, assays with germ-free flies revealed an impact of the gut microbiota on 
paraquat sensitivity of parkin flies. Together, these results suggest a bidirectional 
relationship between the gut microbiota and parkin gene function that affects the severity 




Microbial abundance is increased with age in parkin null animals 
To explore the idea of interactions between Drosophila models of neurodegenerative 
disease and disturbances in the gut microbiome, we measured microbial abundance in the 
autosomal recessive parkinsonism models parkin1, pink1B9, and a double knockout for the 
two DJ1 homologs in Drosophila, DJ-1α and DJ-1β (DJ-1 DKO). An abnormally high or 
low number of live bacteria in the gut indicates disruption of microbial homeostasis. All 
alleles were outcrossed into a common wild-type background for at least five generations 
(w1118; see Methods). We measured microbial abundance in these disease model flies by 
dissecting the gut, homogenizing it by bead-beating, and spreading the homogenate in 
serial 10-fold dilutions on MRS-agar plates, a medium commonly used to rear the gut-
associated microbes of Drosophila (Guo et al. 2014). The number of colonies that grew 
on the plates was counted and used to calculate the Colony Forming Units (CFU), 
representative of the number of live bacteria in the gut. We used males of ages 3d (young 
flies with a sparse microbiome) and 20d (older flies with a well-established abundant 
microbiome).  
 
Consistent with previous findings (Guo et al. 2014;Broderick, Buchon, and Lemaitre 
2014), young flies had few living bacteria in the gut (~103), and this number rose steeply 
in older flies (~105) (Fig 2A). There was no difference in microbial load between control 
flies and any of the disease models at 3d. At 20d, however, we measured a significant 
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increase in the number of live microbes per gut of parkin null flies compared to control 
animals (~106) (Fig 2A). Notably, pink1 and DJ-1 flies did not show a significant 
microbial load increase compared to control flies, even though Parkin and Pink1 regulate 
mitochondrial homeostasis and shape dynamics through the same pathway (Pickrell and 
Youle 2015). This finding indicated a disturbance in the gut microbiota of parkin 
mutants, and that Parkin appears to play a role in the gut microbiome that is independent 
of Pink1 function. 
 
We performed a series of control experiments to assess if the increase in microbial load 
in parkin nulls was simply related to a change in eating or elimination from the gut.  The 
rate of feeding was measured using proboscis print assays. Young and old wild-type and 
parkin male flies were placed individually on a microscope slide covered with sucrose-
gelatin for 20 min (Edgecomb, Harth, and Schneiderman 1994). As the fly ingests 
gelatin, the proboscis leaves a print on the surface of the slide, which was observed and 
scored using Differential Interference Contrast (DIC) microscopy (Fig 2C). The number 
of proboscis prints left on the slide at the end of the assay reflects the rate of feeding. We 
determined that parkin flies eat significantly less than wild-type controls at 3d and 20d 
(Fig 2D). Therefore, the increase in microbial load cannot be due to increased feeding.  
To measure the volume of food in the gut, the flies were fed standard food supplemented 
with FD&C Blue Dye #1. Guts were dissected, homogenized, and the absorbance of the 
sample at 630nm was measured. The assay revealed no significant difference in gut 
volume between old and young parkin mutants and wild-type controls (Fig 2B). 
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Therefore, neither a higher rate of feeding nor a larger volume of food in the gut explains 
the increased microbial load in the gut of parkin mutants. 
 
Since the mutant animals eat at the same rate as wild-type animals, we examined the 
possibility that the rate of elimination could be slower, causing more bacteria to 
accumulate in the gut, by conducting defecation assays with young and old parkin 
mutants and wild-type controls. To measure the rate of defecation, cohorts of 40 animals 
per age and genotype were placed on fly food containing FD&C Blue Dye #1. After 24h 
allowing the blue food to reach steady state in the gut, animals were transferred to fresh 
blue food vials, and the number of blue fecal spots deposited on the walls of the vial was 
counted after 24h. Food vials were laid on their side, so that the climbing defects of 
parkin mutants would not affect the results of the experiment. These experiments 
revealed that young parkin mutants had significantly lower rates of defecation as 
compared to wild-type controls (Fig. 7). Older flies, however, showed no difference in 
defecation rate. The lower defecation rate could be compensated for by the parkin flies 
eating less, and, together with the results of the cell-type specific parkin RNAi 
experiments (see below), the results suggest elimination from the gut is unlikely to be the 
sole contributor to the elevated microbial load in parkin mutants. 
Parkin is required in gut enterocytes to maintain microbial load homeostasis  
We sought to confirm that parkin gene function is required to maintain bacterial numbers 
within a normal range by reducing parkin gene function using RNA interference (RNAi). 
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We screened a series of previously uncharacterized fly lines that express a short hairpin 
RNA against parkin under the control of an upstream activating sequence UAS, and 
identified one line (y1 sc* v1; P{TRiP.HMS01800}attP2/TM3, Sb1, see methods) that 
robustly reduces the parkin transcript expression level. Quantitative RT-PCR for parkin 
showed a decrease in parkin RNA levels when the hairpin was expressed ubiquitously 
compared to a control hairpin against mCherry (da-GAL4 driver; Fig 2A). We determined 
that this parkin RNAi line phenocopied classical parkin loss of function effects, including 
abnormal wing posture (Fig 3B), failure to climb (Fig 3C), and indentations in the dorsal 
thorax (Fig 3D). The phenocopy of multiple parkin loss of gene function effects suggests 
that the RNAi successfully depleted Parkin function. To rule out any potential leakiness 
of the RNAi line, we crossed males with the UAS-hairpin to wild-type virgins in the 
absence of a driver. Quantitative RT-PCR confirmed that these flies did not show a 
decrease in parkin RNA levels compared to a control cross between males carrying the 
UAS-Cherry hairpin and wild-type virgins with no driver (Fig 3E). Together, the RNA 
and genetic experiments indicate the parkin RNAi line successfully depleted the parkin 
activity. 
We expressed the parkin RNAi line ubiquitously with the da-GAL4 driver and measured 
gut microbial load. These results indicated that ubiquitous knockdown of parkin with the 
RNAi line phenocopied the increase in microbial load seen in parkin gene mutants (Fig 
3F), confirming that Parkin activity is required to maintain microbial load homeostasis. 
With the RNAi transgene, knock down of parkin in select cell types is possible, allowing 
us to assess the requirements for Parkin function to maintain microbial load homeostasis 
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in specific cell types. We examined classical tissues required for parkin function (the 
nervous system, muscle, male reproductive system), and in specific cell types within the 
gut. Knockdown of parkin in gut enterocytes (NP1-GAL4 driver) resulted in the increased 
microbial load phenotype (Fig 4A), whereas we observed no change in microbial load 
upon parkin depletion in gut stem cells (esg-GAL4 driver), neurons (elav-GAL4 driver), 
or muscle (24B-GAL4 driver) (Fig 4B-D). These results suggest that parkin gene function 
is required in gut enterocytes to maintain microbial load within wild-type range.  
 
The gut microbiome impacts parkin sensitivity to paraquat 
 The fly gut microbiome has been previously shown to be beneficial for the host, namely 
promoting larval development under conditions of nutrient scarcity (Shin et al. 2011; 
Téfit and Leulier 2017). We considered whether the increased microbial abundance in 
parkin flies may impact features of the parkin mutant. To assess this, we created germ-
free animals by dechorionation of embryos followed by rearing on food supplemented 
with antibiotics (Guo et al. 2014; Ren et al. 2007). Flies mutant for parkin have a known 
sensitivity to oxidative toxins such as paraquat (Pesah et al. 2004). We determined if this 
phenotype was altered in germ-free animals, by subjecting germ-free and conventionally 
raised male flies to a paraquat sensitivity assay, and we observed that germ-free parkin 
flies survived longer on paraquat compared to conventional parkin animals (Fig 5A). 
This finding suggests that the gut microbiome increases sensitivity to paraquat stress of 




We confirmed that improved paraquat resistance of germ-free flies was not due to the 
animals eating less and thus ingesting less of the toxin, as proboscis print assays showed 
no difference in the rate of feeding between germ-free and conventional parkin males 
(Fig 5B). The proboscis print assay also showed no significant difference in feeding 
between parkin and wild-type males in the conditions used for the paraquat sensitivity 
assays (Fig 5C).  
 
We wanted to know whether parkin knockdown selectively in the gut affects paraquat 
sensitivity, or alternatively if paraquat sensitivity involves other tissues that are affected 
by the gut microbiota. To examine this, we used conditional parkin RNAi followed by 
paraquat sensitivity assays.  Ubiquitous RNAi of parkin phenocopied the increased toxin 
sensitivity of the parkin mutant (Fig 6A), whereas parkin RNAi selectively directed to 
gut enterocytes did not cause a significant change in paraquat sensitivity (Fig 6B). These 
results suggest that paraquat sensitivity is not a gut-specific effect but that removing the 
gut microbiome can influence fly characteristics that are beyond the gut, namely 




Parkin mutants show altered relative abundance of microbial species 
 Given the impact of parkin gene function on gut microbial abundance, we were 
interested in whether there were alterations in the composition of microbial species in the 
parkin gut. To define microbial species present, we sequenced 16S rDNA V1-V2 variable 
region amplicons using DNA extracted from dissected guts of 7d and 20d wild-type and 
parkin males. For the young fly timepoint, we chose 7d rather than 3d due to the very low 
microbial abundance in 3d guts. Sequences were clustered into Operational Taxonomic 
Units (OTUs) using open-reference out, picking against the Greengenes database 
(Caporaso et al. 2010); the taxonomic identity of each OTU was assigned using the RDP 
classifier (Wang et al. 2007). Weighted UniFrac showed no difference at 7d in microbial 
composition between parkin null and control males (Fig 7A). At 20d, however, the gut 
microbiomes of parkin nulls and wild-type flies diverged from each other and from the 
microbiome of 7d males (Fig 7A). These data indicated that aged parkin mutants not only 
have a higher gut bacterial load, but also an altered gut species composition compared to 
normal animals.   
 
To define the variation underlying the divergent microbiome of aged parkin animals, we 
analyzed the most abundant gut genera, defined as comprising at least 5% of the total 
reads in any one sample. These data showed that 20d parkin mutants have a decreased 
relative abundance of Paenibacillus and Clostridium reads (Fig 7B). To interrogate 
differences at the species level, representative sequences from each OTU were fetched 
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and batch-aligned to the BLAST 16S rRNA sequence database using nucleotide BLAST. 
If the top hit were more than 99% identical to a sequence from an identified species in the 
database, that species identity was assigned to the OTU (see Figures 8-10 for 
representative alignments). Species-level analysis revealed a switch of the dominant 
Acetobacter species from A. orleanensis to A. pasteurianus in 20d parkin males (Fig 7C). 
These results suggest that parkin mutants have a less complex microbiome and are 
altered for most abundant species, despite a greater load of bacteria in the gut.   
 
Discussion 
In this study we examined the relationship between microbes in the gut and parkin gene 
function. We discovered a five-fold increase of microbial load in the guts of aged parkin 
flies compared to wild-type controls. In vivo RNAi of parkin in gut enterocytes revealed 
that parkin gene function is required in the gut specifically to regulate microbial load. 
Paraquat sensitivity assays with germ-free flies showed a beneficial effect on paraquat 
sensitivity in germ-free parkin animals compared to conventionally reared controls. The 
effect of the parkin mutation on gut microbial composition using 16S rDNA sequencing 
was an altered bacterial species abundance in aged parkin flies.  
 
Unexpectedly, the increase compared to controls of live microbes in the guts of 20d 
parkin flies was not also observed in pink1 flies, even though Pink1 and Parkin regulate 
mitophagy and mitochondrial fission/fusion as parts of the same pathway (Pickrell and 
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Youle 2015). In mammals, Parkin has been shown to ubiquitinate and activate NEMO, a 
member of the NF-κB pathway, in a manner that is independent of Pink1 function 
(Müller-Rischart et al. 2013). Parkin also mediates ubiquitination of intracellular 
pathogens; whether Pink1 is required for this activity is not known (Manzanillo et al. 
2013). Taken together, these observations suggest that Parkin has roles that are 
independent of Pink1 gene function; regulation of microbial homeostasis may be one 
such function. 
 
Our 16S sequencing results revealed altered abundance of Clostridium, Paenibacillus, 
and the species Acetobacter orleanensis and Acetobacter pasteurianus. This raises the 
question of the possible significance of the species and genera that are different between 
parkin nulls and wild-type animals. Clostridium is a diverse genus that includes bacteria 
that cannot be classified otherwise (Dowd et al. 2008). In humans, Clostridium is usually 
associated with pathogenic infection; however, several Clostridium species are known to 
aid in digestion of complex organic matter and protect the host from harmful pathogens 
(Dowd et al. 2008; Kopecný, Hodrová, and Stewart 1996, van der Wielen et al. 2002). 
Paenibacillus can cause opportunistic infections in humans, however, some species 
appear to be protective against pathogens (Grady et al. 2016; Scherling et al. 2009). 
Acetobacter pasteurianus, which was enriched in the parkin mutants, lacks a gene for a 
predicted single-domain oxidoreductase that is present in many other Acetobacter species 
and is beneficial for reducing host triglyceride levels (Newell et al. 2014). 
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parkin flies had higher microbial abundance compared to wild-type controls, but select 
species were reduced rather than enhanced in the microbial composition of 20d parkin 
null guts. The overall alpha diversity score of the parkin mutants was not significantly 
different from controls using available alpha diversity metrics (data not shown). It is 
likely that interactions between bacterial species themselves play a role in regulation of 
gut microbial composition, in addition to the role played by interactions between the 
microbes and the host. Thus, the absence of one or more species could lead to overgrowth 
of other species. The idea of interactions between microbial species in the gut has been 
previously proposed and explored by others as pertaining to the formation of different 
“enterotypes” in the human gut microbiome (Arumugam et al. 2011). It is also possible 
that the spike in gut inflammation that occurs as a result of bacterial overproliferation 
(Guo et al. 2014) could make the gut non-viable for some bacterial species. 
 
Given the increase in microbial load and altered species abundance, an intrinsic 
molecular mechanism by which Parkin regulates microbes in the gut is an exciting 
possibility for future studies. It is unlikely the effects of parkin loss of function on the gut 
microflora are secondary effects of disrupted mitochondrial homeostasis, since pink1 loss 
of function has similar effects on mitochondria, but did not result in a microbial load 
increase.  Parkin may regulate gut microbial homeostasis directly via interactions with 
Drosophila innate immunity pathways. Two immunity pathways are known to regulate 
microbes in the fly gut: the Dual oxidase (Duox) and Imd pathways (Broderick and 
Lemaitre 2012). Duox, a member of the NADPH oxidase family, produces reactive 
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oxygen species that restrict bacterial viability (Kim and Lee 2014). The enzyme activity 
is known to be upregulated by bacterial-derived uracil (Lee et al. 2015). To our 
knowledge, no link between Parkin activity and Duox has been shown at present. 
Alternatively, the Imd pathway is the Drosophila analog of the NF-κB pathway 
(Myllymäki, Valanne, and Rämet 2014). In the fly, the pathway promotes transcription 
and ultimately secretion of antimicrobial peptides (AMPs) in response to DAP-type 
peptidoglycan, a component of bacterial cell walls (Myllymäki, Valanne, and Rämet 
2014). In mammals, Parkin ubiquitinates a member of the NF-κB pathway, NEMO 
(Müller-Rischart et al. 2013), which is essential for NF-κB pathway activation. This 
activity is independent of Pink1(Müller-Rischart et al. 2013).  The Drosophila NEMO 
homolog, IKK-γ, also plays a role in activation of the Imd pathway (Rutschmann et al. 
2000, Ertürk-Hasdemir et al. 2009). In mice, conditional ablation of NEMO leads to 
impaired AMP secretion, intestinal epithelial cell apoptosis, and translocation of bacteria 
into the intestinal mucosa (Nenci et al. 2007). It is possible that parkin regulates 
microbial homeostasis in the gut via ubiquitination of IKK-γ which regulates the Imd 
pathway. If so, measuring the effect of parkin loss of function on antimicrobial peptide 
levels in the gut, and testing for association between parkin and IKK-γ are exciting 
potential next steps. 
 
The observed changes in microbial load and composition, as well as ameliorated toxin 
sensitivity in the absence of a gut microbiome point towards a relationship between the 
microbiome and Parkin activity in the fly gut. These results serve to enhance our 
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understanding of the parkin mutant phenotype and be a primer for exciting studies of 
parkinsonism in mammals.  
Methods 
Fly lines and handling: Flies were grown in standard cornmeal molasses agar medium at 
25°C. parkin1 (w*; P{EP}park1/TM3, Sb1 Ser1, FlyBase ID: FBst0034747) and parkin 
RNAi (y1 sc* v1; P{TRiP.HMS01800}attP2/TM3, Sb1, FlyBase ID: FBst0038333) flies 
were obtained from the Bloomington Stock Center. NP1-GAL4 flies were obtained from 
Sara Cherry (University of Pennsylvania) and pink (pink1B9/FM6) flies were obtained 
from Jongkyeong Chung (Seoul National University). The parkin1 and pink1B9 alleles 
were backcrossed into a homogenous wild-type background (w1118, FlyBaseID: 
FBst0005905) for five generations. DJ1 DKO (w1118;DJ-1αΔ72; DJ-1βΔ93/TM6,Tb) flies 
are described (Meulener et al. 2005). All experiments were performed with male flies 
from lines that were maintained free of Wolbachia. 
Caging: For gut dissections and CFU counting, parkin and wild-type males were aged in 
the same vials to avoid caging effects, since parkin flies can be distinguished by the 
presence of the white gene. In all other experiments caging effects were managed by 
aging animals from different replicates in different vials, so that any variation due to 
caging effects would occurs between different replicates within a group, as well as 
between different groups. 
Gut dissection and CFU counting: Flies were anesthetized, washed 1X in 1mL 10% 
bleach, 1X in 1mL 100% ethanol, and finally rinsed 3X in 1 mL sterile PBS (Sigma-
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Aldrich, St. Louis, MO, USA). 200 µL of the final rinse were spread on an MRS-agar 
plate (BD Diagnostic Systems, Hunt Valley, MD, USA) as a control for the efficacy of 
the wash. Each gut was dissected in a drop of PBS on a sterile microscope slide and 
placed in 200 µL PBS. The gut was homogenized by bead-beating with 1mm tissue-
disruption beads (Research Products International, Mount Prospect, IL, USA) for 30s at 
maximum speed. 10-, 100-, and 1000-fold dilutions of the homogenate were spread on 
MRS-agar plates. All plates were incubated at 30°C for 48h. Bacterial colonies were 
counted and multiplied by the dilution factor to calculate the number of Colony Forming 
Units (CFU) per gut.  
Proboscis prints, blue dye, and defecation assays: Proboscis print assays were 
modified from Edgecomb et al. (Edgecomb, Harth, and Schneiderman 1994). Clean 
microscope slides (Fisher Scientific, Waltham, MA, USA) were briefly dipped in 10% 
sucrose 1% gelatin and left to dry at room temperature in a covered area for 3-4h. Flies 
were anesthetized and placed in individual wells of a 96-well plate. Groups of ten flies 
were arranged in two columns of five wells. Each group was covered by a strip of wax 
paper and a gelatinated microscope slide. Flies were incubated for 30 min at room 
temperature to recover from the anesthesia, during which time the outline of each well 
was traced on the slide using a thin permanent marker. At the end of the incubation 
period, the strip of wax paper was swiftly removed allowing contact between the fly and 
the sweet gelatin coat. Plates were inverted, allowing the flies to walk on top of the slide 
for 20 min at room temperature. The number of prints left on each slide was counted 
using Differential Interference Contrast (DIC) microscopy.  
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For the blue dye assays, flies were fed for 48h on standard food supplemented with 2.5% 
w/v FD&C Blue Dye #1 (SPS Alfachem, Orange, NJ, USA). Five guts per age and 
genotype were dissected, homogenized and the absorbance of the sample at 630nm was 
measured with a spectrophotometer.  
For the defecation assays, cohorts of 40 animals per age and genotype were tested using 
ten flies per vial on fly food containing 2.5% w/v FD&C Blue Dye. Animals were left on 
the dye for 24h. Flies were transferred to fresh blue food vials and the number of blue fecal 
spots deposited on the walls of the vials was counted after 24h.  
Germ-free flies: Standard fly food was autoclaved and upon cooling supplemented with 
yeast extract (Fisher Scientific, Waltham, MA, USA) to 100 g/L and an antibiotic 
cocktail of kanamycin (1mM; Fisher Scientific, Waltham, MA, USA), ampicillin (650 
µM; MediaTech, Manassas, VA, USA), and doxycycline (650 µM; Sigma-Aldrich, St. 
Louis, MO, USA). Food was dispensed in empty fly bottles at 50 mL per bottle in a 
laminar flow cabinet and left to solidify. A 12h collection of fly embryos was rinsed in 
100% ethanol, dechorionated in 10% bleach for 2 min, and immediately rinsed 3X in 
sterile PBS. Embryos were placed on the prepared fly food and overlaid with sterile 
glycerol. Germ-free fly lines were maintained on sterile food for up to 3-4 generations 
using a laminar flow cabinet. Flies were monitored for bacterial contamination by 
homogenizing larvae and testing for bacterial growth on MRS-agar plates.  
Paraquat sensitivity assays: Flies were transferred to empty vials at 20 flies per vial 
(Genesee Scientific, San Diego, CA, USA), starved for 6h, then transferred to vials 
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containing 2.5% agar (LabScientific, Highlands, NJ, USA), 10% sucrose (Sigma-Aldrich, 
St. Louis, MO, USA), 25mM Paraquat (MP Biomedicals, Santa Ana, CA, USA). Vials 
were incubated at 25°C and the number of dead flies in each vial was counted every 8h 
until all flies were dead or until 168 hr (7d) had passed.  
16S rDNA sequencing: Twenty guts per sample were dissected as described above and 
subjected to DNA extraction using the PSP Spin Stool DNA Purification Kit (Stratec 
Biomedical, Birkenfeld, Germany). PCR of the V1-V2 variable regions was performed 
using the 27F – 338R primer pair (27F: 5′-AGAGTTTGATCMTGGCTCAG-3′; 338R: 
5′-TGCTGCCTCCCGTAGGAGT-3′) with the following program: 94°C for 4 min, 94°C 
for 30s, 58°C for 30s, 72°C for 40s, 30 total amplification cycles, 72°C for 10 min, then 
hold 4°C. Three PCR reactions were pooled and the PCR product was purified using the 
Agencourt AMPure XP PCR purification kit (Beckman Coulter, Brea, CA, USA) and 
sequenced using MiSeq (Illumina, San Diego, CA, USA).  
Sequencing analysis was carried out using the QIIME suite (Caporaso et al. 2010). Paired 
reads were joined and quality filtered using a Phred score cutoff of 20. OTUs were picked 
using an open-reference OTU picking algorithm with the Uclust alignment method and 
99% identity. OTUs with less than 10 reads were removed from the analysis. The most 
abundant sequence was selected as a representative sequence for each OTU and used to 
assign a taxonomic classification for each OTU using the RDP classifier version 2.12 




Climbing assays, thoracic indentations, and abnormal wing posture scoring: Flies 
were raised and aged on standard cornmeal molasses agar food vials at a density 20 flies 
per vial. Number of flies with abnormal wing posture was scored on anaesthetized 
animals in the vial. For climbing assays, flies were flip-transferred in empty vials 
(Genesee Scientific, San Diego, CA, USA) with a line marking a distance 8 cm above the 
bottom of the vial, near the top. Vials were tapped and the number of animals that crossed 
the mark 10s after tapping was recorded. The presence or absence of thoracic indents was 
scored on anesthetized animals on a fly pad. Experiments were repeated in 3 independent 
biological replicates with 55-60 flies per replicate. 
Real-time quantitative PCR: Total RNA from crushed whole males was purified using 
the Trizol reagent (Ambion, Foster City, CA, USA) following the reagent manual. The 
RNA was DNase treated using TURBO DNase (Ambion, Foster City, CA, USA) 
according to the kit instructions. After DNase treatment, the RNA was Trizol purified 
again. Reverse transcription was carried out using the High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, Waltham, MA, USA) according to the kit 
manual. Real time PCR was carried out using the Fast SYBR Green Mastermix (Applied 
Biosystems, Waltham, MA, USA) following the kit instructions. Primers used for RT 
PCR had the following sequences: parkin F: 5’-CGGATGTGAGTGATACCGTGT-3’; 
parkin R: 5’-ATAAACTGACGCTCGCCCAA-3’. 
Statistics: Statistical analyses pertaining to the processing of 16S rDNA sequencing 
results were carried out using QIIME’s built-in functions (Caporaso et al. 2010). All 




Figure 2. parkin mutants exhibit an elevated microbial load with age.  
(A) Microbial load of wild-type (w1118) males and male mutants for parkinsonism-
associated genes at ages 3d and 20d. Dissected and homogenized individual guts were 
serially diluted and a fraction of the diluted homogenate was spread on MRS-agar plates. 
Colonies grown were counted and used to calculate the colony forming units (CFU) per 
gut. The experiment was repeated in four independent biological replicates of six 
individual guts each per age and genotype. DJ1 DKO stands for DJ1 double knockout: 
DJ-1αΔ72; DJ-1βΔ93. **p<0.01, ANOVA followed by Tukey’s post-test. All comparisons 
not marked with a double asterisk (**) are not statistically significant. (B) Blue-dye 
feeding assay to measure volume of food in the gut of wild-type (w1118) and parkin1 
mutant males at 3d and 20d. Flies were placed on food containing 2.5% w/v FD&C blue 
dye #1 for 48 hr. Five guts per genotype/age group were dissected in PBS, homogenized, 
and the absorbance at 630 nm was measured.  The experiment was repeated in three 
independent biological replicates. n.s. not significant, ANOVA followed by Tukey’s 
post-test. (C) Example image of prints left by the fly proboscis on a 1% gelatin-, 5% 
sucrose- coated slide. (D) Proboscis print assay to measure the rate of feeding of wild-
type (w1118) and parkin1 mutant males at 3d and 20d. Animals were enclosed in individual 
chambers on top of a 1% gelatin-, 5% sucrose- coated slide and incubated for 20 min 
without disturbance. The number of proboscis prints left on the surface of the slide was 
counted. The experiment was repeated in ten independent biological replicates of ten 
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Figure 3 Knockdown of parkin phenocopies the parkin1 mutant. 
(A-D) Validation of effective knockdown of parkin by in vivo expression of siRNA 
hairpin. (A) Real-time PCR for parkin in total RNA from whole 7d males expressing no 
hairpin, a hairpin against mCherry, or a hairpin against parkin. **p<0.01, ANOVA 
followed by Tukey’s post test. (B) Fraction of flies exhibiting abnormal wing posture 
among 7d males expressing no hairpin, a hairpin against mCherry, or the hairpin against 
parkin, compared to parkin1 flies. Flies were aged on standard food and the number of 
animals with held-up wings was counted. The experiment was conducted in biological 
triplicate using 55-60 flies per replicate. **p<0.01, n.s. – not significant, ANOVA 
followed by Tukey’s post test. (C) Climbing assay of 7d males expressing no hairpin, a 
hairpin against mCherry, or the hairpin against parkin, as well as parkin1 null flies. Flies 
were aged on standard food and placed in empty vials. The number of animals that 
climbed to the top of the vial 10s after tapping was recorded. Experiment was repeated in 
3 independent biological replicates with 55-60 flies per replicate. **p<0.01, n.s. – not 
significant, ANOVA followed by Tukey’s post test. (D) Fraction of flies exhibiting 
thoracic indentations among 7d males expressing no hairpin, a hairpin against mCherry, 
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or the hairpin against parkin, compared to parkin1 flies. Flies were aged on standard food 
and the number of animals with a collapsed thorax was counted. Experiment was 
repeated in 3 independent biological replicates with 55-60 flies per replicate. **p<0.01, 
n.s. – not significant, ANOVA followed by Tukey’s post test. (E) Real-time PCR for 
parkin in total RNA from whole 7d control or parkin RNAi males, in which the UAS-
hairpin line was crossed to a wild-type line with no driver. n.s. – not significant, 
Student’s t-test. (F) Gut microbial load of 20d control or parkin RNAi males, in which 
the UAS-hairpin line was crossed to a wild-type line with no driver. n.s. – not significant, 
Student’s t-test. (G) Gut dissection followed by live colony counting in flies expressing 
mCherry or Parkin RNAi ubiquitously. The gut dissection procedure was as in Fig 1A.  
The experiment was repeated in four independent biological replicates of six individual 
















Figure 4. parkin is required in gut enterocytes to maintain microbial homeostasis. 
 (A-D) Microbial load in guts of 20d control or parkin RNAi males, in which knockdown 
was carried out selectively in (A) gut enterocytes, (B) gut stem cells, (C) neurons, or (D) 
muscle cells with indicated GAL4 drivers. Guts were dissected as in Fig 1A. The 
experiment was repeated in four independent biological replicates of six individual guts 













Figure 5. Absence of the gut microbiota affects paraquat sensitivity of parkin 
mutants. 
 (A) Survival curve on 20 mM paraquat of 0-3d conventional or germ free wild-type and 
parkin1 mutant males. 100 animals per treatment and genotype were starved for 6h then 
placed on 10% sucrose-, 2.5% agar- food containing 20 mM paraquat. Survival was 
measured every 8h for 168h (over 7d). The experiment was repeated in three independent 
biological replicates. p<0.0001, log-rank test. (B) Proboscis print assay to measure the 
rate of feeding of conventionally reared and germ-free wild-type and parkin1 mutant 
males at ages 0-3d. Assay was carried out as in Fig 1 but with flies grown on food 
supplemented with 100 g/L yeast and starved for 6h prior to the assay. n.s. - not 
significant, ANOVA followed by Tukey post-test. (C) Proboscis print assay to measure 
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the rate of feeding of control and parkin1 mutant males at ages 0-3d grown on standard 























Figure 6. Depletion of parkin in gut enterocytes does not affect paraquat sensitivity. 
 (A-B) Paraquat sensitivity assays with 0-3d control or parkin RNAi males, in which 
knockdown was carried out ubiquitously (A, da-GAL4 driver) or selectively in gut 
enterocytes (B, NP1-GAL4 driver). Paraquat sensitivity assays were carried out as in Fig 
4A. The experiment was repeated in three independent biological replicates of 100 




Figure 7. parkin loss of function affects gut microbial composition.  
16S rDNA amplicon sequencing of guts from 7d and 20d wild-type and parkin males. 
(A) Principle coordinate analysis shows similar microbial composition at age 7d, but at 
age 20d the gut microbiomes of wild-type and parkin1 mutant diverge. (B-C) Most 
common genera (defined as more than 5% of total reads in at least one sample) in (B) 7d 
male guts and (C) 20d male guts. (D-I) Relative abundance (measured as percentage of 
total reads in that sample) of Acetobacter species detected in (D) 7d males and (E) 20d 
males, Lactobacillus species detected in (F) 7d males and (G) 20d males, Paenibacillus 
species detected in (H) 20d males, and Clostridium species detected in (I) 20d males. 





Figure 8. Decreased defecation rate in young parkin male guts. 
Cohorts of 40 males were incubated on fly food containing FD&C Blue Dye #1 for 24h. Flies 
were transferred to fresh blue food vials, and after another 24h incubation period, the number of 
blue fecal spots on the walls of the vials were counted. The experiment was repeated in four 









Figure 9. Alignment between sequenced Acetobacter 16S rDNA amplicons and best 
matches from BLAST search. 
Reads were fetched from the set of representative sequences for each OTU and BLAST searched 
against the NCBI 16S rDNA sequence database. Three pairs of reads and their BLAST top hit 
were aligned using Clustal Omega. Mismatching nucleotides that can be used to differentiate 
between species are highlighted in red. VF12_6 was identified as Acetobacter orleanensis. 











Figure 10. Alignment between sequenced Lactobacillus 16S rDNA amplicons and 
best matches from BLAST search. 
Reads were fetched from the set of representative sequences for each OTU and BLAST searched 
against the NCBI 16S rDNA sequence database. Three pairs of reads and their BLAST top hit 
were aligned using Clustal Omega. Mismatching nucleotides that can be used to differentiate 
between species are highlighted in red. VF12-13508 was identified as Lactobacillus pentosus. 
VF12_238 was identified as Lactobacillus plantarum. VF13_1569280 was identified as 









Figure 11. Alignment between sequenced Paenibacillus 16S rDNA amplicons and 
best matches from BLAST search. 
Reads were fetched from the set of representative sequences for each OTU and BLAST searched 
against the NCBI 16S rDNA sequence database. Three pairs of reads and their BLAST top hit 
were aligned using Clustal Omega. Mismatching nucleotides that can be used to differentiate 
between species are highlighted in red. VF32_4730694 was identified as Paenibacillus chibensis. 
VF32_5232385 was identified as Paenibacillus glucanolyticus. VF32_4749292 was identified as 







Figure 12. New discoveries on Parkin in the context of what is known. 
Red rectangles and diamonds indicate new roles and new phenotypes for Parkin 
described here. Green rectangles indicate pathway targets. Cyan rectangles indicate 
biological functions. Violet diamonds indicate associated phenotypes. Our results suggest 
Parkin plays a role in maintenance of gut microbial load and composition. Loss of 
function of Parkin causes dysbiosis of the gut. The gut microbiome of the fly itself affects 
toxin sensitivity of parkin mutants. Upon activation by Pink1, Parkin ubiquitinates 
various targets in damaged mitochondria to mark them for mitophagy, among which the 
mitofusins Mfn1 and Mfn2, thus preventing fusion of the damaged mitochondria with 
healthy ones (Deas, Wood, and Plun-Favreau 2011). Pink1 and Parkin also mediate 
intestinal stem cell proliferation through an unknown pathway (Koehler et al. 2017). 
Parkin ubiquitinates the NF-κB protein NEMO independently of Pink1, resulting in 
activation of the NF-κB pathway and enhanced transcription of the mitochondrial fusion 
and apoptosis regulation protein OPA1 (Müller-Rischart et al. 2013). Parkin ubiquitinates 
intracellular bacteria, targeting them for degradation. Whether Pink1 is required for this 
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CHAPTER 3: CONCLUSIONS, OUTSTANDING QUESTIONS, AND 
POTENTIAL APPROACHES 
 
Here I describe the implementation of Drosophila as a model to study the relationship 
between microbes in the gut and neurodegenerative disease-associated phenotypes. My 
dissertation work demonstrates how the fly facilitates a wide array of approaches for 
study of the gut microbiome, such as directed screens, the use of germ-free animals, 16S 
rDNA sequencing, and genetic experiments. Using these approaches, I characterized a 
relationship between the gut microbiome and the parkinsonism gene parkin.  I observed a 
five-fold increase compared to control in the number of live microbes inhabiting the guts 
of older parkin males, an effect which was also caused by RNAi depletion of Parkin in 
gut enterocytes specifically. Since the gut microbiome is tightly regulated by the fly host, 
an increase in microbial numbers of this magnitude suggests an impactful role for Parkin 
in microbial regulation, and given that pink1 animals were unaffected, this role is likely 
independent of Pink1 activity. Microbiome composition was also affected by parkin loss 
of function, with decreased relative abundance of one Acetobacter species and the genera 
Clostridium and Paenibacillus. This finding suggests that some bacterial taxa are more 
sensitive than others to the environmental changes occurring in the guts of parkin-
depleted animals, and that perhaps this perturbation of gut microbiome homeostasis could 
contribute to some of the disease-associated characteristics of the parkin parkinsonism 
model. I observed a beneficial effect of the removal of the gut microbiome in general on 
paraquat sensitivity in the parkin mutant, suggesting that the presence of a gut 
microbiome that is out of homeostasis does indeed have an impact on parkin animals. My 
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work deepens our understanding of the parkin mutation characteristics and raises a 
number of questions for future study.  
 
The mechanism by which Parkin regulates gut microbial homeostasis 
One question is how parkin affects microbial load and composition in the gut. A simple 
possibility is that changes in the gut microbiota are a secondary effect of sickness or 
damaged mitochondria in the gut or elsewhere in the fly. Although possible, this is not 
very likely given that the microbial load of pink1 flies, which are in the same microbial 
pathway as parkin (Clark et al. 2006), is not significantly different from control animals.  
 
Pathways that regulate immunity in the gut are the most likely candidate. In Drosophila, 
there are two such pathways – the Dual oxidase (Duox) and the Imd pathway (Bae, Choi, 
and Lee 2010; Myllymäki, Valanne, and Rämet 2014). Duox generates reactive oxygen 
species in response to bacterial-derived uracil binding to a yet unknown G-protein 
coupled receptor on the cell membrane (Lee et al. 2013; Lee et al. 2015). Currently, there 
is no known direct link between Parkin and the Duox pathway, but examining the effect 
of parkin loss of function on Duox levels and activity in the fly gut is a possibility for 
future study. Important questions include: Are the levels of components of the Duox 
pathway increased? Does altering the expression of Duox pathway components (key 
targets include the MAPK cascade and Atf2) affect Duox levels and microbial load in 
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parkin mutants? Can a physical association between Parkin and a Duox pathway 
component be shown? 
 
The Imd pathway leads to secretion of antimicrobial species (AMPs) in response to DAP-
type peptidoglycan binding to certain peptidoglycan recognition proteins (PGRPs) 
(Myllymäki et al. 2014). Imd is the Drosophila homolog of the mammalian NF-κB 
pathway, and Parkin has been shown to ubiquitinate a member of the NF-κB pathway, 
NEMO (Müller-Rischart et al. 2013). Notably, ubiquitination of NEMO is independent of 
Pink1 stabilization (Müller-Rischart et al. 2013). The Drosophila NEMO homolog, IKK-
γ is the regulatory subunit of the IKK complex (IKKβ being the active kinase subunit), 
which contributes to Relish activation by phosphorylating it (Ertürk-Hasdemir et al. 
2009).  In mice, ablation of NEMO in the gut results in decreased secretion of AMPs, 
apoptosis of intestinal epithelial cells, and bacterial invasion into the intestinal mucosa 
(Nenci et al. 2007). Given these results, it is possible that in Drosophila, Parkin regulates 
gut microbial homeostasis via ubiquitination of IKK-γ. Key experiments would include 
measuring levels of antimicrobial peptides in wild-type and parkin guts, testing for 




The mechanism through which the gut microbiota impact the parkin mutant’s 
sensitivity to paraquat 
Another outstanding question is how the gut microbiota impact paraquat sensitivity in 
parkin flies. Given that removal of the gut microbiome improves survival of parkin 
animals after paraquat exposure, several possibilities exist.  
 
Bacterial overproliferation in very old wild-type animals has been shown to cause 
oxidative stress through hyperactivation of Duox (Guo et al. 2014). Similarly, bacterial 
overgrowth due to the parkin mutation could cause oxidative stress which would 
compound the oxidative stress occurring as a result of paraquat toxicity. Key questions of 
interest include: Are Duox levels elevated in the guts of parkin flies? Does 
overexpression of genes which are protective from oxidative stress, such as DJ-1, result 
in no significant difference in paraquat toxicity between germ-free and conventionally 
raised parkin flies? Does ectopic activation of Duox using bacterial-derived uracil only 
result in no significant difference in paraquat toxicity between germ-free and 
conventionally raised parkin flies?  
 
Another possibility is that metabolism of paraquat by the gut microbiota enhances 
paraquat toxicity. Many bacterial species have been shown to be able to use paraquat as 
an electron carrier in the redox cycle, generating reactive oxygen species (ROS) (Haley 
2008). ROS generated by gut bacteria through redox cycling would not only be toxic in 
85 
 
themselves but also increase gut permeability, allowing even more toxic paraquat to be 
taken up by the fly. Paraquat can also be used as a coenzyme by bacteria in the reduction 
of sulfate, thiosulfate, hydroxylamine, nitrate, among other compounds (Haley 2008), 
therefore it is possible that paraquat could mediate increased secretion of a gut bacterial 
metabolite which is toxic to the host. Specific questions include: Do cultured bacteria 
from parkin guts give off ROS in the presence of paraquat in vitro? Do cultured bacteria 
from parkin guts metabolize paraquat in vitro? Can a bacterial metabolite be isolated 
through chromatography approaches that is toxic if fed to the animals?  
 
The identity of microbiome species which could impact the parkin mutant’s 
sensitivity to paraquat 
Changes in microbial composition in the guts of parkin animals raises the question if it is 
any one species, a combination of several species, or the presence of gut microbiota in 
general that impacts parkin mutant flies’ sensitivity to paraquat. 16S rDNA sequencing 
reveal changes in the abundance of the genera Clostridium and Paenibacillus, and of the 
species Acetobacter orleanensis and Acetobacter pasteurianus. Currently, little is known 
about these bacterial taxa. Clostridium is a diverse genus that includes some bacterial 
species that cannot be classified otherwise (Dowd et al. 2008). The genus is most known 
for causing pathogenic infection in humans; however, several Clostridium species have 
been reported to aid in digestion of complex organic matter and protection from 
pathogens (Dowd et al. 2008; Wielen, et al. 2002; Kopečný, Hodrová, and Stewart 1996). 
Similarly, some species of Paenibacillus are known to cause opportunistic infections in 
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humans, however, Paenibacillus can also be protective against pathogens (Grady et al. 
2016; Scherling et al. 2009). Acetobacter pasteurianus, which replaced Acetobacter 
orleanensis as the dominant Acetobacter species in the parkin mutants, lacks a predicted 
single-domain oxidoreductase gene which is found in many other Acetobacter species 
and which helps reduce host triglyceride levels (Newell et al. 2014). Experiments of 
interest include isolating and culturing of individual species found in control and parkin 
null flies’ guts, followed by monoassociation with parkin flies and paraquat sensitivity 
assays to clarify if specific species are responsible for contributing to increased paraquat 
sensitivity of parkin mutants. Genome sequencing of species isolated from parkin guts 
would help identify potential bacterial genes of interest which may impact the parkin 
mutant. Deletion of the genes of interest or ectopic expression in a strain that does not 
naturally express them would help confirm the significance of the gene for the parkin 
mutant.  
 
parkin mutants had an increased number of live bacteria in the gut compared to controls, 
but sequencing revealed decreased rather than increased relative abundance of select 
species in the microbial composition of 20d parkin guts. Although the overall alpha 
diversity score of the parkin gut microbiome was not significantly different from control 
using available alpha diversity metrics (data not shown), this result suggests that 
interactions between bacterial species themselves influence gut microbial composition, in 
addition to the role played by interactions between the microbes and the host. Thus, the 
absence of one or more species could lead to overgrowth of other species. The idea of 
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interactions between microbial species in the gut has been previously proposed and 
explored by others as pertaining to the formation of different “enterotypes” in the human 
gut microbiome (Arumugam et al. 2011). Furthermore, interactions between several 
species rather than any one species have been shown to influence fly metabolism (Newell 
and Douglas 2014), and these interactions could similarly influence paraquat sensitivity. 
It is also possible that oxidative stress and the spike in gut inflammation that occur as a 
result of bacterial overgrowth (Guo et al. 2014) could make the host gut less habitable for 
some bacterial species. Key experiments would include isolating gut microbes from wild-
type flies, followed by colonization of germ-free parkin guts with different individual 
species removed and monitoring of microbial load, which would help determine if the 
absence of any one species causes bacterial overgrowth. Alternatively, if colonizing 
germ-free parkin flies with a full complement of gut microflora isolated from wild-type 
controls results in bacterial overproliferation and a shift in microbial composition towards 
that of parkin mutants, then the likely cause for the altered microbial composition would 
be the parkin loss of function itself. Alterations in Duox levels followed by colonization 
of parkin flies with wild-type microflora would determine if oxidative stress as a result of 
overgrowth or some other consequence of the parkin mutation is responsible for the shift 
in microbial composition. 
 
The results described in this dissertation work suggest Parkin plays a before-
undocumented role in regulation of gut microbial homeostasis, and conversely, that the 
gut microbiome has an impact on parkinsonism as modeled in the fly. This work deepens 
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our understanding of the parkin mutant phenotype and sets a foundation for further 
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PROTOCOLS FOR TECHNIQUES USED IN THIS DISSERTATION WORK 
Fly gut dissection and Plating 
Materials: 
• Ringer’s solution, Millipore filtered, autoclaved and aliquoted in 50 mL conicals: 
o 182 mM KCl 
o 46 mM NaCl 
o 3 mM CaCl2 
o 10 mM Tris-HCl 
o adjust the pH to 7.2 
Note:  PBS can also be used instead of Ringers but NOT just water. 
 
• Forceps #5; must be very sharp. At least two pairs are needed for dissection, but 
keep an extra pair in case one of them bends during the dissection.  
• Ethanol, 190 proof, obtained from university facilities. 
• 50% Clorox in Millipore-filtered water. 
• Autoclaved nuclease-free 1.5 mL tubes (Ambion, AM12400) 
• Kimwipes, wrapped in packs of several wipes and autoclaved. 
• Plain microscope slides (Fisher Scientific, 12-544-1), soaked in 10% Clorox for at 
least 5 minutes, rinsed in Millipore-filtered water, individually wrapped in 
aluminum foil, and autoclaved. 
• Transfer pipets, individually wrapped, sterile (Fisher Scientific, 1371121). 
• Petri-Spread disposable spreaders, individually wrapped, sterile (USA Scientific, 
2977-5510). 
• Tissue disruption beads, 1 mm diameter (Fisher, 50-212-147) 
• Agar plates1:  
o MRS-agar: 70 g/L Lactobacilli MRS agar (BD Difco, 288210) or… 
o NR-agar: 23 g/L Nutrient agar (BD Difco, 212000) 
o Medium mixed in Millipore filtered water, autoclaved at 121*C for 30 
minutes, and poured in polystyrene tissue culture plates 100mmX20mm. 
• An incubator set to 30*C. 
 
NOTE: Reverse the left and right directions in this protocol if you’re left-handed. 
 
                                                           
1 Linlin Guo et al., “PGRP-SC2 Promotes Gut Immune Homeostasis to Limit Commensal Dysbiosis and 




1. Sterilize the flies by washing in 50% Clorox: 
a. Prepare more flies than you will need for dissection. If you’re new to gut 
dissection, prepare at least double the flies than you will need.  
b. Don’t dissect more than 10-15 flies at a time. If you need to dissect more 
flies than that, separate them into batches, and wash the flies and set up the 
dissection table separately for each batch. 
c. Anesthetize the 10-15 flies and transfer them to a sterile microfuge tube 
using a small paintbrush.  
d. Quickly pipet 1 mL of 50% Clorox on top of the flies.  
e. Invert the tube several times to mix the flies with the bleach, so that there 
are no air bubbles surrounding the flies. The bleach must also come in 
contact with the walls and lid of the tube to sterilize them. 
f. Briefly vortex the flies until they are fully submerged in the bleach. Older 
animals will sink more easily, while younger animals may need a longer 
spin. Do not centrifuge them for longer than 30 seconds at maximum 
speed in a tabletop centrifuge. 
g. Incubate the flies in the bleach for 2 minutes. Do not leave them in the 
bleach for longer than 5 minutes. 
h. In a tissue culture hood, pipet out and discard the bleach using a P1000 
pipette. 
i. In a tissue culture hood, rinse the flies in 1 mL 100% ethanol by pipetting 
the ethanol into the tube and immediately pipetting it out using a P1000 
pipette. 
j. Still in the hood, use the same pipetting technique to rinse the flies three 
times in sterile Ringer’s solution. 
k. Pipet in 1 mL of fresh sterile Ringer’s solution and place the microfuge 
tube with the flies on ice.  
2. Setup the dissection table. I dissect the flies on a table near the tissue culture 
hood. Make sure everything necessary is on the table within reach. Once 
dissection starts, you want to spend as little time as possible looking for 
instruments or reagents. If in the middle of dissection, you realize you need 
something not within reach, go get it between dissecting two different guts, not 
while dissecting a gut. To prevent contamination, the guts must be exposed to the 
open air for as short a time as possible while being dissected.  
a. Spray the entire table surface with 70% ethanol and wipe it clean with a 
kimwipe.  
b. On the table, put on your left-hand side the ice bucket with the microtube 
of washed flies. Then put in the ice bucket: 
i. a 50 mL conical with 190-proof ethanol, 
ii. a 50 mL conical with 50% Clorox, 
iii. a 15 mL conical with about 10 mL sterile Ringer’s solution. 




d. Place some individually wrapped transfer pipets on your right, farther than 
the forceps. You’ll need a new transfer pipet for every fly you dissect (and 
remember you prepared extra flies), and two for the blank control.  
e. Farthest from you on the right, but still within easy reach, place the beaker 
with microscope slides individually wrapped in aluminum foil and 
sterilized. Next to the slides place a pack of autoclaved kimwipes. 
3. Blank control: 
a. This control is exposed to the outside of the flies, the slide, the forceps, 
and the air, before being spread on an agar plate. 
b. Spray your hands with 70% ethanol from a spray bottle. 
c. Take one slide, unwrap it from the aluminum foil, and place it on the stage 
of the dissection microscope. Make sure your fingers only touch the sides 
of the slide, as far as possible from the center. 
d. Unwrap a transfer pipet by peeling the wrapping from the side where the 
bulb is. 
e. With your left hand, take the microfuge tube with the flies from the ice 
and open it.  
f. Use the transfer pipet to pipet out a little bit of the Ringer’s solution from 
the microfuge tube (2-3 drops is enough). 
g. Squeeze out the Ringer’s solution in the center of the slide.  
h. With your right hand, grab both forcep pairs. Make sure your arm or any 
other part of your body does not pass over the slide. Otherwise, skin cells 
or dust with bacteria may fall on the slide and contaminate it. 
i. Keep the forceps’ tips in the air. With your left hand, take the 50 mL 
conical with the bleach and open it. You must keep holding the cap in 
your hand and never put it down when it is open. 
j. Dip about 2/3 of the forceps into the bleach and gently swirl them for 
about 10 seconds to sterilize them. Avoid touching the walls or bottom of 
the conical with the tips of the forceps, because this will bend them and 
they won’t be usable for dissection anymore. 
k. Lift the forceps from the bleach, close the conical, and place it back on 
ice. Keep the forceps’ tips in the air and over the ice so that any stray 
drops of bleach land into the ice and not on the table surface (it will 
corrode) or on your body or clothes. 
l. With your left hand, take the 50 mL conical with the ethanol and open it. 
Keep holding the cap in your hand and don’t put it down. 
m. Dip about 2/3 of the forceps into the ethanol and gently swirl them for 
about 5 seconds. 
n. Lift the forceps from the ethanol, close the conical, and place it back on 
ice. Wipe the forceps with an autoclaved kimwipe.  
o. Hold the forceps with both hands and swirl them into the Ringer’s solution 
on the slide to imitate dissection. Make sure you don’t bend the tips. 
p. Unwrap a fresh transfer pipet, aspirate the Ringer’s solution from the 
slide, go to the tissue culture hood, and squeeze out the Ringer’s solution 
in the center of an agar plate. 
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q. Using a clean cell spreader, spread the solution onto the surface of the 
plate by rotating the plate with one hand and repeatedly sliding the 
spreader from the center to the edges and back with the other hand. Apply 
very gentle pressure to avoid damaging the agar. Do not go all the way to 
the very edge, as colonies there are difficult to image and count. Stop 
spreading when the liquid is evenly distributed and appears to have “sunk” 
into the agar. 
r. Close the plate, label the lid, and put the plate in a 30*C incubator with the 
lid facing upwards. Do not turn the plate upside down yet, so that the 
bacteria have time to sink into the agar. 
4. Dissecting a gut: 
a. Follow the same cycle for dissecting each gut. The steps are very similar 
to the blank control above. 
b. Spray your hands with 70% ethanol from a spray bottle. 
c. Take one slide, unwrap it from the aluminum foil, and place it on the stage 
of the dissection microscope. 
d. Unwrap a fresh transfer pipet. 
e. Use the transfer pipet to take out 2-3 drops of sterile Ringer’s solution 
from the 50 mL conical and squeeze it out in the center of the slide.  
f. Grab both forceps with your right hand. With your left hand, take the 50 
mL conical with the bleach and open it.  
g. Dip about 2/3 of the forceps into the bleach and gently swirl them for 
about 10 seconds to sterilize them. 
h. Lift the forceps from the bleach, close the conical, and place it back on 
ice. 
i. With your left hand, take the 50 mL conical with the ethanol and open it. 
Keep hold the cap in your hand and do not put it down. 
j. Dip about 2/3 of the forceps into the ethanol and gently swirl them for 
about 5 seconds. 
k. Lift the forceps from the ethanol, close the conical, and place it back on 
ice.  
l. Wipe the forceps with an autoclaved kimwipe. 
m. With your left hand, open the microfuge tube with the flies and use the 
forceps to grab a fly and place it in the drop of Ringer’s solution on the 
slide. It is tricky to hold both forceps with one hand and pick up a fly with 
one of them, but you cannot put them down. If you do put one pair down, 
sterilize them by rinsing in bleach and ethanol again before you begin the 
dissection. When moving the fly, hold it by the wings or legs to avoid 
piercing the thorax or abdomen with the sharp forceps.  
n. To dissect the fly, use the forceps in your left hand to hold the fly in place 
on the slide. With your right hand, first remove the head and put it aside. 
Then remove the wings and legs. Make an incision in the midline of the 
dorsal side of the abdomen, going from the anterior to the posterior side. 
Grab the cuticle covering the abdomen along the incision line and 
carefully tear it open to expose the gut and the organs surrounding it. 
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Then, organ by organ, remove everything attached to the gut. When 
removing the cuticle covering the thorax and the trachea, be careful not to 
pierce or tear the crop. Remove the crop last, by slicing the vessel 
connecting the crop to the cardia.  
i. Different people have different ways of dissecting out the gut, and 
this is just one way. However you decide to dissect the gut, it is 
essential to: 
1. Not tear the gut. 
2. Remove the crop but not tear or pierce it. Tearing the crop 
has affected the CFU counts I get from spreading a 
dissected gut on a plate, probably because food is stored 
there. 
3. It is not too essential to remove all the malpighian tubules 
attached to the gut, do your best. 
o. When the gut is dissected, place it in its own sterile microfuge tube with 
200 µL sterile Ringer’s solution in it. Label the tube. 
p. In the microbiome hood, pour tissue disruption beads into the microfuge 
tube, approximately to the 100 µL mark.  
q. Place the closed microfuge tube into the bead beater and beat at max speed 
for 30 seconds. 
r. Return the microfuge tube to the microbiome hood. 
s. Dilution and spreading: 
i. I usually spread each gut in three 10-fold serial dilutions as 
explained below. This allows to conveniently count up to 106 
colonies and has been sufficient so far. 
ii. Spread 20 µL of the undiluted gut homogenate on a fresh agar 
plate. This is your 10-fold “dilution.” Rotate the plate with one 
hand and repeatedly slide the spreader from the center to the edges 
and back with the other hand. Apply very gentle pressure to avoid 
damaging the agar. Do not go all the way to the very edge, as 
colonies there are difficult to image and count. Stop spreading 
when the liquid is evenly distributed and appears to have “sunk” 
into the agar. 
iii. Close the lid and label the plate. 
iv. Take 2 µL of the undiluted gut homogenate and mix it with 20 µL 
sterile Ringer’s solution in a fresh microfuge tube. This is your 
100-fold dilution. 
v. Take 2 µL of the 100-fold dilution and mix it with 20 µL sterile 
Ringer’s solution in a fresh microfuge tube. This is your 1000-fold 
dilution. 
vi. Spread the 100-fold and 1000-fold dilutions on fresh agar plates as 
explained above. Discard the spreader, it is disposable and should 
be used only once. 




u. Incubate them for two days before you count colonies or photograph them.  
 
Making antibiotic food bottles for axenic flies 
 
Materials: 
• DEPC-treated water (Ambion, AM9906). The water we use is supplied in 50 mL 
bottles and one bottle is designated for making axenic vials only.  
• Fly food from the Cell center:  
o We use cornmeal molasses agar medium. The food is prepared by the 
university facilities. 
o I use very fresh food (0-2 days old).  
• Polypropylene fly food bottles from the Cell center. 
• Kanamycin sulfate (Fisher Scientific, BP906-5) 
• Ampicillin, sodium salt (Corning Cellgro, 61-238-RH) 
• Doxycycline hyclate (Sigma, D9891-5G) 
• Yeast extract (Sigma, Y0500-1KG) 
• Nipagin (Sigma, H3647-100G) 
 
1. Decide how many bottles you want to make. For each bottle you need 50 mL of 
food. Calculate the total volume of food + 10% extra and add it to a large 
autoclavable glass flask. 
2. Take as many fly food bottles as you will need and cover them with aluminum 
foil.  
3. Add 100g yeast extract per 1L of food to the food in the flask. Cover the flask 
with aluminum foil. 
4. Take another glass flask large enough to contain at least half the volume of the 
food you will be making and cover with aluminum foil. 
5. Take a glass graduated cylinder and cover with aluminum foil.  
6. Autoclave for 30 min at 120*C (liquids setting on autoclave) the flask with the 
food, the empty flask, the graduated cylinder, and the fly food bottles.  
7. While autoclaving is in progress, make a 50X stock solution of 32 mg/mL 
ampicillin, 32 mg/mL doxycycline, and 50 mg/mL kanamycin in DEPC treated 
water. The solution must be made fresh every time, since the antibiotics are less 
stable in water and freezing the solution may cause them to precipitate. You will 
need to vortex a lot before the antibiotics fully dissolve in the water.  
8. Make a 100X solution of 20% w/v Nipagin in ethanol (to achieve 0.2% final 
concentration in food).  
9. When the autoclaved food has cooled down enough to work with, place it in the 
microbiome hood, add the Nipagin to the flask, and swirl the flask to mix. 
10. Use the graduated cylinder to measure out half of the total volume of the food you 
were planning on making and pour that into the empty flask.  
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11. Add the antibiotic stock solution to the flask and swirl to mix.  
12. Pour the antibiotic and non-antibiotic food in bottles. I add about 50 mL to each 
bottle. The antibiotic-free food is your negative control on which you can rear 
conventional flies. 
13. Keep the food inside the hood to cool down and set, then while still in the hood 
cover the bottles with buzz plugs. 
14. Store the food in the cold room and use within a week. 
 
Dechorionation for axenic flies 
 
Materials:  
Autoclave the following items for 30 min at 120*C (liquid setting on autoclave): 
• PBS 
• A small aliquot of glycerol, you will need 200 µL for each germ-free fly bottle 
you make (Sigma, G9012) 
• fly food bottles (prepare using the protocol above) 
These materials do not need to be autoclaved:  
• 50% Clorox  
• 190-proof ethanol  
• Dissection scope   
• Fly brush 
• Forceps 
• Empty 15 mL conicals 
• In addition, you must have embryos ready from flies that have been in a cage for 
~12hrs on plastic petri dishes with apple juice agar.  
 
1. Set the timer to 2 minutes.  
2. Remove all yeast paste and hatched larvae from the embryo collection dish with 
the forceps. Pipet 3-4 mL 190-proof ethanol in the plastic petri dish where the 
embryos are collected. Under the microscope, dislodge embryos from the agar 
with a brush. Be gentle, if you are breaking off the appendages of the embryos 
with the brush, you are being too forceful.  
3. Aspirate the ethanol and embryos from the dish surface with a serological pipet 
and transfer them to a 15 mL conical.   
4. The embryos naturally settle to the bottom of the conical when submerged 
ethanol. Wait for this to happen, aspirate the ethanol and add 5 mL fresh ethanol. 
Close the conical and invert up and down for several times to rinse the embryos.  
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5. Aspirate the ethanol as well as possible and add 5 mL bleach. Start the timer. 
During the dechorionation, close and invert the conical several times.  
6. As soon as the timer is done, spin embryos to the bottom at 1200 rpm for ~ 10s 
(just use the quick spin option of the tabletop centrifuge).  
7. Aspirate the bleach, add 5 mL PBS and spin down again.  
8. Aspirate the PBS. Repeat the PBS rinse step 2 more times.   
9. Aspirate the final PBS rinse until ~200 µL PBS is left on the bottom with all the 
embryos in it. With a P1000 take 200 µL sterile glycerol and add it to 
the embryos then immediately suck in the PBS-glycerol mixture with as many 
embryos as possible. Pipet the embryos on top of the sterile fly food.  
10. Leave embryos at 25*C to develop.  
 
DNA Extraction using the PSP stool kit 
Materials: 
• Mini-BeadBeater-16 (BioSpec). 
• PSP Spin Stool DNA Plus Kit (Stratec Molecular, 1038110300) 
• Two heat blocks 
• Disruptor Beads (0.1 mm, ISC Bioexpress, S-7340-18) aliquoted to microfuge 
tubes by pouring up to the 100 µL mark. Each microfuge tube must be closed, a 
whole was pierced in the lid with a needle, and all bead tubes must be autoclaved 
together in a beaker. 
• Microcentrifuge  
• Fisherbrand RNase-Free Disposable Pellet Pestles with tubes (Fisher 12-141-368) 
 
 
Note: all extraction work is performed inside a tissue culture hood whenever possible.  
- Turn on heat blocks to 95oC and 70oC. Place elution buffer on top of heat block at 70oC.  
- Thaw or re-suspend proteinase K. 
- Add EtOH to the wash buffers as needed.  
 
Fly gut prep 
1. Dissect guts from 10 flies (3-5 days old).  Freeze in -80o C or go ahead to the next 





1. Grind the samples (whole fly or guts) completely with pestle; 
2. Fill the sample tube with 1 mL stool stabilizer buffer.  Add the autoclaved beads 
and close the cap.  
3. Bead beat in three 30-second intervals with a 10 second pause in between to 
homogenize the sample. 
4. Incubate it at 95oC for 15 minutes. Mix by inverting the tube every 2’ or so. Keep 
something heavy on top of the tubes while incubating to prevent them from 
popping. Place tubes on ice for 30" to 1’ to cool them down. 
5. Centrifuge at max speed for 1’ to pellet the debris. 
6. Transfer the supernatant (about 1 mL) to an InviAdsorb tube (make sure the 
InviAdsorb matrix is not on the cap).   
7. Add additional 400 μL of Stool Stabilizer buffer to the supernatant in the 
InviAdsorb tube. (An apparent volume of ~1.5 mL with the InviAdsorb matrix is 
expected). 
8. Vortex for 15” 
9. Incubate at room temperature for 1’. 
10. Centrifuge at max speed for 3’. 
11. Transfer supernatant to a 1.5 mL receiver tube (provided) and REPEAT spin. 
12. Transfer all supernatant (about 1mL) to a 2 mL safe-lock Eppendorf tube 
(provided) containing 31.25 μL of Proteinase K ( the ratio between supernatant to 
proteinase K  is 800 μL supernatant to 25 μL proteinase K). And quickly vortex 
the sample. (There should be left over liquid here, which may be extracted 
separately if more DNA is needed from the sample. If so, adjust the proteinase K 
proportionally to the amount of sup used).  
13. Incubate at 70oC for 10’.  
14. Add 1/2 vol of the sup (about 500 μL) of binding buffer to the tube. 
15. Mix by pipetting up and down and transfer 700 μL to a RTA spin filter (the filter 
holds up to 700 μL. Load more times to the SAME column for samples of low 
concentration).  
16. Incubate for 1’ at RT 
17. Centrifuge at max speed for 2 minutes, discard the filtrate and collection tube 
18. Transfer the RTF filter to a new 2mL receiver tube. 
19. Add 500 μL of Wash Buffer 1 to the filter. 
20. Spin at max speed for 1 minute and discard the flow through and receiver tube. 
21. Transfer the RTA filter onto a new 2 mL receiver tube.  
22. Add 700 μL of Wash Buffer 2 to the RTA filter. 
23. Spin at max speed for 1 minute and discard the flow through and return the 
sample to the receiver tube. 
24. Spin at max speed for 3 minutes to remove EtOH traces (very important! Lots of 
residual EtOH are removed in this step) 
25. Transfer the RTA filter to a 1.5 mL receiver tube.  
26. Add 100 μL of warm elution buffer and incubate 1’ at room temperature. 
27. Centrifuge at max speed for 1 minute. 
28. Discard the filter and measure the absorbance of the eluted material at 260nm to 
quantify the DNA. Store it at -20oC.  
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PHH3 immunofluorescence of guts 
 
Materials 
• Sterile PBS 
• 70% ethanol 
• Clean microscope slides 
• Transfer pipettes  
• Sharpened forceps 
Fixing and staining: 
• Primary antibody: Rabbit monoclonal (Abcam, ab32107) 
• Secondary antibody: Alexa 594 – Goat anti-rabbit (Invitrogen A-11037) 
• PBT – 0.1% Tween 20 in PBS 
• 4% paraformaldehyde in PBT 
• PBTA – PBT with 1% BSA 
Mounting and imaging: 
• Mounting solution 
• Fly brush 
• Clean slides and coverslips 




1. Anesthetize flies thoroughly in CO2 and transfer to a microfuge tube using a 
brush.  
2. Wash flies by adding 1 mL 70% ethanol to the microfuge tube and pipetting it out 
after 1-2 s. 
3. Rinse 3X with 1mL PBS, using fresh PBS for each rinse.  
4. After 3 rinses, add a fresh 1mL PBS and keep the flies in it for the remainder of 
the dissection.  
5. Keep the microfuge tube on ice for the remainder of the dissection. 
6. Pipette 10 uL onto the slide.  
7. Sever the head and the esophagus using a pair of forceps. Detach the thorax from 
the abdomen to expose the gut. Peel apart the thorax without tearing it, then peel 
apart the abdomen. Sever the connection between the gut and the crop.  
8. Transfer the gut to a PCR tube with 20 uL 4% formaldehyde in PBT.  
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Fixing and staining: 
1. Place microfuge tube on a rocker and incubate for 30 minutes at room 
temperature. 
2. Rinse quickly 3X with PBT. 
3. To block, add 1mL PBTA and rock at room temperature for 1 hour.  
4. Add 20 uL primary antibody solution (1:1000 in PBTA) and stain overnight at 
4*C with rocking.  
5. Wash 3 times with PBTA, 10 minutes each with rocking at 4*C.  
6. Add DAPI solution (1:10,000) and secondary antibody (1:1000) in PBTA, stain 
overnight (better quality) or 2h (faster) with rocking at 4*C. 
7. Wash 3 times with PBTA, 20 minutes each with rocking at 4*C.  
8. Proceed to mounting and imaging.  
Mounting and imaging: 
1. Using forceps carefully transfer guts on a clean microscope slide with a drop of 
mounting solution (10-20uL).  
2. Carefully place a coverslip on top of the guts and press VERY lightly. Remove 
any liquid oozing from the sides of the coverslip with a kimwipe.  
3. Let slide dry overnight at room temperature inside a drawer or in some other dark 
dry place.   
4. Image with confocal. 
 
 
Preparing paraquat-sucrose-agar vials for paraquat sensitivity assays 
Materials: 
• Sucrose (Sigma 84097) 
• Agar (LabScientific B366) 
• Paraquat (MP Biomedicals 02195323.2) 
• Empty fly vials (Genesee Scientific, 32-116SB) 
• Standard lab equipment (microwave, Erlenmeyer flasks, weighing paper or boats, 




1. Decide how many empty fly vials you will need. I use 5 vials per experimental 
group per replicate. Each vial will house 20 flies, for a total of 100 flies per 
experimental group per replicate. Place the required amount of vials on a rack, 
bring the rack of vials to a chemical safety hood, and set them aside until it is time 
to fill them.  
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2. Decide on the volume of paraquat-sucrose-agar food you will need. I add 5 mL of 
food per vial and make 10% extra food to account for loss during pipetting.  
3. Weigh out the necessary amount of paraquat. The final concentration in the food 
should be 25 mmol. Wear gloves, lab coat, and a mask for your safety, paraquat is 
very toxic! Bring the weighed paraquat crystals to the chemical safety hood. Be 
careful, the crystals are very light and can easily disperse due to fast movement. 
Place the paraquat in the chemical safety hood and set it aside until it is time to 
add it to the food.  
4. Weigh out enough sucrose for a final concentration of 10% w/v and add it to an 
empty Erlenmeyer flask. You will need a much larger flask than the final food 
volume, otherwise the food can boil over when it is microwaved. 
5. Weigh out enough agar for a final concentration of 2.5% w/v and add it to the 
flask. 
6. Fill a graduated cylinder with Millipore water to the desired food volume, and 
pour the water in the flask. The sucrose, agar, and paraquat contribute a negligible 
amount to the final food volume.  
7. Microwave the sucrose-agar-water mixture until the sucrose and agar are fully 
dissolved. Occasionally pause the microwave, take out the flask, and swirl the 
mixture. Wear heat-resistant gloves, the flask becomes very hot! 
8. When food is completely microwaved, bring the flask to the chemical safety hood 
and wait until it is cool enough to touch with a regular lab glove, but still very 
warm.  
9. Pour the paraquat crystals carefully to the center of the flask. Swirl slowly for at 
least 30 min to evenly mic the dissolved paraquat. Wear gloves and a mask. 
10. Using a serological pipet, add 5 mL of the food to each vial. Make sure to pipet in 
the center of the vials, so that food doesn’t flow down and solidify on the walls. 
Do not add the last 0.5 mL in the pipet to the vial, because it will spray all over 
the walls of the vial. Pipet them out in the flask instead.  
11. Cover the vials with cheesecloth or kimwipes and let them sit in the chemical 
safety hood until the food cools down and solidifies. Do not add cotton plugs 
before the food has fully cooled, this will result in soggy vials.  
12. When the food has cooled, add cotton plugs to the vials. They can be taken out 
and used in the paraquat assay, but wear gloves and a lab coat while handling 
them at all times.  
13. Label and place any solid waste (i.e. leftover food) and serological pipets in the 
chemical safety hood to be disposed of according to EHRS instructions. Carefully 
wash all equipment used with detergent and water.  
14. Store used paraquat vials in a labeled ziplock bag in the chemical safety hood to 
be disposed of according to EHRS instructions.  
 
